Franco M Muggia

Biosketch / Results /

Franco M Muggia, M.D.

Professor;
Departments of Medicine (Residency Program) and Medicine (Perlmutter Cancer Center)
NYU Medical Oncology Associates

Clinical Addresses

160 EAST 34TH STREET
NEW YORK, NY 10016
Hours: Mon. 12 - 5; Tue. 12 - 5; Wed. 12 - 5; Thu. 12 - 5; Fri. 12 - 5
Handicap Access: yes
Phone: 212-731-5433
Fax: 212-731-5545

« Back to Results

Medical Specialties

Cancer, Medical Oncology

Medical Expertise

Breast Cancer, Breast Oncology, Gynecologic Cancers, Gynecologic Oncology

Languages

Italian, French, Spanish

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, AFFINITY EXCHANGE- ESSENTIAL, Beech Street, CIGNA EPO/POS, Cigna HMO, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, ELDERPLAN, GHI CBP, Group Health Insurance (GHI), HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICAID, HIP MEDICARE, HIP POS, HealthNet, MAGNACARE PPO, MULTIPLAN/PHCS PPO, Medicare, Multiplan, NY MEDICAID OPT-OUT (OPRA), NYS EMPIRE PLAN, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Freedom Plan, Oxford Liberty, Oxford Medicare, Private Healthcare Systems (PHCS), UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER UNITED EXCHANGE- COMPASS, UPN Elite (Island Group/Humana/etc), United Healthcare, Vytra

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

1968 — Ab Internal Medicine - Internal Medicine
1973 — Ab Internal Medicine (Medical Oncology)
1974 — Ab Internal Medicine (Hematology)

Education

1957-1961 — Cornell University Medical College, Medical Education
1961-1962 — Bellevue Hospital Center (Medicine), Internship
1962-1964 — Hartford Hospital (Medicine), Residency Training
1964-1967 — Columbia Univ. Col. of Phy. & Surg. (Hematology-Onlcology), Clinical Fellowships

« Back to Results

Research Interests

Treatment of ovarian and endometrial cancer; intraperitoneal therapy of gastric and ovarian cancer; liposomal drug delivery; phase I clinical trials with new anticancer drugs.

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Targeted Agents and Oxaliplatin-containing Regimens for the Treatment of Colon Cancer
Bonetti, Andrea; Giuliani, Jacopo; Muggia, Franco
2014 Jan;34(1):423-434, Anticancer research
— id: 807182, year: 2014, vol: 34, page: 423, stat: Journal Article,

Introduction: why a supplement on taxanes?
Muggia, Franco M
2014 Apr;25(4):481-481, Anti-cancer drugs
— id: 898242, year: 2014, vol: 25, page: 481, stat: Journal Article,

Platinum and Other Heavy Metal Coordinating Compounds in Cancer Chemotherapy: Overview of Verona ISPCC XI
Muggia, Franco; Leone, Roberto; Bonetti, Andrea
2014 Jan;34(1):NP-NP NP, Anticancer research
— id: 807172, year: 2014, vol: 34, page: NP, stat: Journal Article,

'BRCAness' and Its Implications for Platinum Action in Gynecologic Cancer
Muggia, Franco; Safra, Tamar
2014 Feb;34(2):551-556, Anticancer research
— id: 806962, year: 2014, vol: 34, page: 551, stat: Journal Article,

Effect of Germline BRCA Mutations on Response to Chemotherapy and Outcome of Recurrent Ovarian Cancer
Safra, T; Rogowski, O; Muggia, F
2014 Apr 2014;:e362-e362, Current oncology (Toronto, Ont.)
— id: 953612, year: 2014, vol: , page: e362, stat: Journal Article,

The Effect of Germ-Line BRCA Mutations on Response to Chemotherapy and Outcome of Recurrent Ovarian Cancer
Safra, Tamar; Rogowski, Ori; Muggia, Franco M
2014 Jan;:551-556, International journal of gynecological cancer
— id: 807162, year: 2014, vol: , page: 551, stat: Journal Article,

Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer
Shavit, Linda; Lifschitz, Meyer D; Gabizon, Alberto; Kwa, Maryann; Muggia, Franco; Slotki, Itzchak
2014 Jan;85(1):213-213, Kidney international
— id: 806852, year: 2014, vol: 85, page: 213, stat: Journal Article,

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
Zagar, Timothy M; Vujaskovic, Zeljko; Formenti, Silvia; Rugo, Hope; Muggia, Franco; O'Connor, Brigid; Myerson, Robert; Stauffer, Paul; Hsu, I-Chow; Diederich, Chris; Straube, William; Boss, Mary-Keara; Boico, Alina; Craciunescu, Oana; Maccarini, Paolo; Needham, David; Borys, Nicholas; Blackwell, Kimberly L; Dewhirst, Mark W
2014 Aug;30(5):285-294, International journal of hyperthermia
— id: 1195622, year: 2014, vol: 30, page: 285, stat: Journal Article,

Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis
Diaz-Padilla, Ivan; Romero, Nuria; Amir, Eitan; Matias-Guiu, Xavier; Vilar, Eduardo; Muggia, Franco; Garcia-Donas, Jesus
2013 Oct;88(1):154-167, Critical reviews in oncology-hematology
— id: 627852, year: 2013, vol: 88, page: 154, stat: Journal Article,

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity
Kobrinsky, B; Joseph, S O; Muggia, F; Liebes, L; Beric, A; Malankar, A; Ivy, P; Hochster, H
2013 Nov;72(5):1073-1078, Cancer chemotherapy & pharmacology
— id: 598422, year: 2013, vol: 72, page: 1073, stat: Journal Article,

Clinical features of taxane neuropathy
Kudlowitz, David; Muggia, Franco
2013 Nov;:213-213, Anti-cancer drugs
— id: 807202, year: 2013, vol: , page: 213, stat: Journal Article,

Defining risks of taxane neuropathy: insights from randomized clinical trials
Kudlowitz, David; Muggia, Franco
2013 Sep;19(17):4570-4577, Clinical cancer research
— id: 519442, year: 2013, vol: 19, page: 4570, stat: Journal Article,

Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) Cisplatin
Kwa, Maryann; Edwards, Susan; Downey, Andrea; Reich, Elsa; Wallach, Robert; Curtin, John; Muggia, Franco
2013 Oct;:213-213, Annals of surgical oncology
— id: 807142, year: 2013, vol: , page: 213, stat: Journal Article,

Ovarian Cancer: A Brief Historical Overview of Intraperitoneal Trials
Kwa, Maryann; Muggia, Franco
2013 Oct;:213-213, Annals of surgical oncology
— id: 807152, year: 2013, vol: , page: 213, stat: Journal Article,

Combination of irinotecan and bevacizumab for heavily pretreated recur-rent ovarian cancer: A phase II trial
Ling, H; Muggia, F; Speyer, J; Curtin, J; Blank, S; Boyd, L; Pothuri, B; Li, X; Goldberg, J; Tiersten, A
2013 July 2013;Conference:(44th):e12-, Gynecologic oncology
— id: 452992, year: 2013, vol: Conference:, page: e12, stat: Journal Article,

Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?
Marquez-Medina, D; Chachoua, A; Martin-Marco, A; Desai, A M; Garcia-Reglero, V; Salud-Salvia, A; Muggia, F
2013 Nov;15(11):959-964, Clinical & translational oncology
— id: 611782, year: 2013, vol: 15, page: 959, stat: Journal Article,

An evaluation of molecular markers that predict maximal surgical cytoreduction: A Gynecologic Oncology Group trial
Miller, C; Miller, A; Hamilton, C; Alvarez-Secord, A; Havrilesky, L; Muggia, F; Farley, J
2013 July 2013;Conference:(44th):e20-, Gynecologic oncology
— id: 452982, year: 2013, vol: Conference:, page: e20, stat: Journal Article,

Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia, Franco
2013 ;18(3):245-247, Oncologist
— id: 807222, year: 2013, vol: 18, page: 245, stat: Journal Article,

Novel taxanes
Muggia, Franco; Kudlowitz, David
2013 Dec;:213-213, Anti-cancer drugs
— id: 807192, year: 2013, vol: , page: 213, stat: Journal Article,

A pharmacokinetic evaluation of topotecan as a cervical cancer therapy
Musa, Fernanda; Blank, Stephanie; Muggia, Franco
2013 Feb;9(2):215-224, Expert opinion on drug metabolism & toxicology
— id: 213422, year: 2013, vol: 9, page: 215, stat: Journal Article,

Dose-dependent pharmacokinetic (PK) interaction of pegylated liposomal doxorubicin (PLD) with escalating doses of veliparib in a phase I study
Pothuri, B; Muggia, F; Sparano, J A; Blank, S V; Curtin, J P; Chuang, E; Hershman, D L; Chen, A; Liebes, L
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 451992, year: 2013, vol: 31, page: , stat: Journal Article,

Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report
Sharma, Sharan Prakash; Muggia, Franco
2013 ;7:335-335, ecancermedicalscience
— id: 807212, year: 2013, vol: 7, page: 335, stat: Journal Article,

RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial
Singh, J C; Stein, S; Volm, M; Smith, J A; Adams, S; Meyers, M; Speyer, J L; Novik, Y; Schneider, R; Formenti, S; Muggia, F; Jhaveri, K L; Goldberg, J D; Heese, S; Li, X; Davis, S; Tiersten, A
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 452012, year: 2013, vol: 31, page: , stat: Journal Article,

A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer
Stein, Stacey M; Tiersten, Amy; Hochster, Howard S; Blank, Stephanie V; Pothuri, Bhavana; Curtin, John; Shapira, Ilan; Levinson, Benjamin; Ivy, Percy; Joseph, Benson; Guddati, Achuta Kumar; Muggia, Franco
2013 Nov;23(9):1577-1582, International journal of gynecological cancer
— id: 598582, year: 2013, vol: 23, page: 1577, stat: Journal Article,

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature
Teplinsky, Eleonora; Cheung, Derrick; Weisberg, Ilan; Jacobs, Ramon E A; Wolff, Martin; Park, James; Friedman, Kent; Muggia, Franco; Jhaveri, Komal
2013 Sep;141(2):167-172, Breast cancer research & treatment
— id: 551472, year: 2013, vol: 141, page: 167, stat: Journal Article,

HE4: another 'player' in the epithelial tumor marker arena?
Teplinsky, Eleonora; Muggia, Franco
2013 Jun;27(6):556, 562-556, 563, Oncology
— id: 472132, year: 2013, vol: 27, page: 556, 562, stat: Journal Article,

Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer?
Cannon, Timothy L; Lai, Dominic W; Hirsch, David; Delacure, Mark; Downey, Andrea; Kerr, Alexander R; Bannan, Michael; Andreopoulou, Eleni; Safra, Tamar; Muggia, Franco
2012 May;:1541-1546, Oncologist
— id: 174216, year: 2012, vol: , page: 1541, stat: Journal Article,

Postoperative Intraperitoneal 5-Fluoro-2'-Deoxyuridine Added to Chemoradiation in Patients Curatively Resected (R0) for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
2012 Feb;19(2):478-485, Annals of surgical oncology
— id: 135531, year: 2012, vol: 19, page: 478, stat: Journal Article,

Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin
Gu, Ping; Wu, Jennifer; Newman, Elliot; Muggia, Franco
2012 ;2012:131659-131659, International journal of hepatology
— id: 174218, year: 2012, vol: 2012, page: 131659, stat: Journal Article,

Phase II trial of irinotecan plus bevacizumab for heavily pretreated recurrent ovarian cancer
Jain, S S; Makeyev, Y G; Muggia, F; Speyer, J L; Curtin, J P; Blank, S V; Boyd, L R; Pothuri, B; Fishman, D; Li, X; Goldberg, J D; Tiersten, A
2012 20 May 2012;30(15):-, Journal of clinical oncology
— id: 250082, year: 2012, vol: 30, page: , stat: Journal Article,

Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integration
Joseph, Sasha O; Wu, Jennifer; Muggia, Franco M
2012 Nov;26(11):1021-30, 1035, Oncology
— id: 213702, year: 2012, vol: 26, page: 1021, stat: Journal Article,

Is Renal Thrombotic Angiopathy a Potential Problem in the Chronic Treatment of Ovarian Cancer?
Kwa, Maryann; Baumgartner, Robert; Shavit, Linda; Barash, Irina; Michael, Jeffrey; Puzanov, Igor; Kopolovic, Juri; Rosengarten, Ora; Blank, Stephanie; Curtin, John P; Gabizon, Alberto; Muggia, Franco
2012 May;:1534-1540, Oncologist
— id: 174215, year: 2012, vol: , page: 1534, stat: Journal Article,

Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma
Lewin, S; Dezube, D; Guddati, A K; Mittal, K; Muggia, F; Klein, P
2012 02 Oct 2012;6(1):- 271, ecancermedicalscience
— id: 197962, year: 2012, vol: 6, page: , stat: Journal Article,

SALVAGE RADIOTHERAPY FOR SOLITARY FOCUS OF DISEASE PROGRESSION COULD ALLOW MAINTAINING THE EFFICACY OF ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER
Marquez-Medina, Diego; Chachoua, Abraham; Gasol Cudos, Ariadna; Muggia, Franco
2012 JUL;7(7):S119-S119, Journal of thoracic oncology
— id: 174424, year: 2012, vol: 7, page: S119, stat: Journal Article,

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
Monk, Bradley J; Herzog, Thomas J; Kaye, Stanley B; Krasner, Carolyn N; Vermorken, Jan B; Muggia, Franco M; Pujade-Lauraine, Eric; Park, Youn C; Parekh, Trilok V; Poveda, Andres M
2012 Apr;:2361-2368, European journal of cancer (1990)
— id: 174217, year: 2012, vol: , page: 2361, stat: Journal Article,

Bevacizumab in ovarian cancer: unanswered questions
Muggia, Franco
2012 May;72(7):931-936, Drugs
— id: 166799, year: 2012, vol: 72, page: 931, stat: Journal Article,

Clinical drug development in 2012
Muggia, Franco
2012 Jun;26(3):xi-xii, Hematology-oncology clinics of North America
— id: 165622, year: 2012, vol: 26, page: xi, stat: Journal Article,

Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine
Muggia, Franco; Diaz, Isabela; Peters, Godefridus J
2012 Apr;21(4):403-408, Expert opinion on investigational drugs
— id: 161187, year: 2012, vol: 21, page: 403, stat: Journal Article,

Phase i study of the PARP inhibitor ABT-888 (veliparib) and pegylated liposomal doxorubicin (PLD) in recurrent ovarian (ov) and breast (br) cancers
Pothuri, B; Sparano, J; Blank, S; Curtin, J; Chuang, E; Hershman, D; Tiersten, A; Liebes, L; Chen, A; Muggia, F
2012 March 2012;125:S22-S22, Gynecologic oncology
— id: 162928, year: 2012, vol: 125, page: S22, stat: Journal Article,

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study
Rubatt, JM; Darcy, KM; Tian, C; Muggia, F; Dhir, R; Armstrong, DK; Bookman, MA; Niedernhofer, LJ; Deloia, J; Birrer, M; Krivak, TC
2012 Jan;:421-426, Gynecologic oncology
— id: 161222, year: 2012, vol: , page: 421, stat: Journal Article,

BREAST CANCER RECURRENCES AT THE CHEST WALL (BCRCW) WHEN STANDARD TREATMENTS (TX) HAVE FAILED: LYSO-THERMOSENSITIVE LIPOSOMAL DOXORUBICIN (LTLD) plus MILD LOCAL HYPERTHERMIA (MLH)
Rugo, H. S.; Formenti, S. C.; Myerson, R. J.; Diederich, C. J.; O'Connor, B. M.; Matzkowitz, A. J.; Muggia, F.
2012 SEP;23 9 9:130-130, Annals of oncology
— id: 181672, year: 2012, vol: 23 9 9, page: 130, stat: Journal Article,

Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer
Singh, J C; Stein, S; Volm, M; Smith, J A; Novik, Y; Speyer, J L; Meyers, M; Adams, S; Omene, C O; Muggia, F; Schneider, R; Formenti, S; Davis, S; Beardslee, B; Tiersten, A
2012 20 May 2012;30(15):-, Journal of clinical oncology
— id: 249952, year: 2012, vol: 30, page: , stat: Journal Article,

A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density
Smith, Julia; Dilawari, Asma; Ursin, Giske; Andreopoulou, Eleni; Checka, Christina; Axelrod, Deborah; Guth, Amber; Toth, Hildegard; Utate, Minerva; Carapetyan, Karen; Reich, Elsa; Diflo, Thomas; Muggia, Franco
2012 Apr;32(4):1327-1331, Anticancer research
— id: 164364, year: 2012, vol: 32, page: 1327, stat: Journal Article,

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
Verschraegen, C F; Czok, S; Muller, C Y; Boyd, L; Lee, S J; Rutledge, T; Blank, S; Pothuri, B; Eberhardt, S; Muggia, F
2012 Dec;23(12):3104-3110, Annals of oncology
— id: 205202, year: 2012, vol: 23, page: 3104, stat: Journal Article,

Targeted therapy: its status and promise in selected solid tumors part I: areas of major impact
Wu, Jennifer; Joseph, Sasha O; Muggia, Franco M
2012 Oct;26(10):936-943, Oncology
— id: 184592, year: 2012, vol: 26, page: 936, stat: Journal Article,

Cisplatin with Capecitabine: Tolerance and Activity in a Phase I/II Study Preferentially Enrolling Patients with Gastric Cancer
Wu, Jennifer; Ryan, Theresa; Levinson, Benjamin; Newman, Elliot; Hochster, Howard S; Muggia, Franco
2012 Mar;32(3):939-945, Anticancer research
— id: 159861, year: 2012, vol: 32, page: 939, stat: Journal Article,

The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study
Alvarez Secord, Angeles; Darcy, Kathleen M; Hutson, Alan; Huang, Zhiqing; Lee, Paula S; Jewell, Elizabeth L; Havrilesky, Laura J; Markman, Maurie; Muggia, Franco; Murphy, Susan K
2011 Nov;123(2):314-319, Gynecologic oncology
— id: 161223, year: 2011, vol: 123, page: 314, stat: Journal Article,

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer
Andreopoulou, Eleni; Chen, Thomas; Liebes, Leonard; Curtin, John; Blank, Stephanie; Wallach, Robert; Hochster, Howard; Muggia, Franco
2011 Aug;68(2):457-463, Cancer chemotherapy & pharmacology
— id: 161219, year: 2011, vol: 68, page: 457, stat: Journal Article,

CA-125 surveillance for women with ovarian, fallopian tube or primary peritoneal cancers: What do survivors think?
Boyd, L.; Bedell, S.; Curtin, J.; Wallach, R.; Pothuri, B.; Muggia, F.; Tiersten, A.; Blank, S.
2011 MAR ;121(1):S64-S64, Gynecologic oncology
— id: 132764, year: 2011, vol: 121, page: S64, stat: Journal Article,

Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results
Czok, S.; Jewell, A.; Shawki, S.; Boyd, L.; Smith, H.; Blank, S.; Muller, C.; Verschraegen, C.; Muggia, F.
2011 MAR ;121(1):S83-S83, Gynecologic oncology
— id: 132765, year: 2011, vol: 121, page: S83, stat: Journal Article,

Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when?
Echarri Gonzalez, Maria Jose; Green, Robin; Muggia, Franco M
2011 Feb;25(2):1344-1351, Oncology
— id: 161284, year: 2011, vol: 25, page: 1344, stat: Journal Article,

Loss of p27KIP1 Expression in Fully-staged Node-negative Breast Cancer: Association with Lack of Hormone Receptors in T1a/b, but not T1c Infiltrative Ductal Carcinoma
Mirchandani, Deepu; Roses, Daniel F; Inghirami, Giorgio; Zeleniuch-Jacquotte, Anne; Cangiarella, Joan; Guth, Amber; Safyan, Rachael Ann; Formenti, Silvia C; Pagano, Michele; Muggia, Franco
2011 Dec;31(12):4401-4405, Anticancer research
— id: 149934, year: 2011, vol: 31, page: 4401, stat: Journal Article,

BRCA genes: lessons learned from experimental and clinical cancer
Muggia, F; Safra, T; Dubeau, L
2011 Jan;22 Suppl 1:i7-10, Annals of oncology
— id: 161225, year: 2011, vol: 22 Suppl 1, page: i7, stat: Journal Article,

Conclusions: fruits of the convergence of laboratory, clinic and public
Muggia, F; Smaldone, V; Paradiso, A
2011 Jan;22 Suppl 1:i67-i68, Annals of oncology
— id: 161226, year: 2011, vol: 22 Suppl 1, page: i67, stat: Journal Article,

Delayed Neoplastic and Renal Complications in Women Receiving Long-term Chemotherapy for Recurrent Ovarian Cancer
Muggia, Franco; Cannon, Timothy; Safra, Tamar; Curtin, John
2011 Jan 19;103(2):160-161, Journal of the National Cancer Institute
— id: 120643, year: 2011, vol: 103, page: 160, stat: Journal Article,

Hereditary breast and ovarian cancer: risks and challenges. 10-12 September 2009: Bari, Italy. Introduction
Paradiso, A; Muggia, F
2011 Jan;22 Suppl 1:i5-i6, Annals of oncology
— id: 161227, year: 2011, vol: 22 Suppl 1, page: i5, stat: Journal Article,

Bortezomib: understanding the mechanism of action
Piperdi, Bilal; Ling, Yi-He; Liebes, Leonard; Muggia, Franco; Perez-Soler, Roman
2011 Nov;10(11):2029-2030, Molecular cancer therapeutics
— id: 146229, year: 2011, vol: 10, page: 2029, stat: Journal Article,

BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin
Safra T; Lucia B; Nicoletto MO; Rolnitzky L; Pelles-Avraham S; Geva R; Donach ME; Curtin J; Novetsky A; Grenader T; Lai WC; Gabizon AA; Boyd L; Muggia FM
2011 Oct;10(10):2000-2007, Molecular cancer therapeutics
— id: 136569, year: 2011, vol: 10, page: 2000, stat: Journal Article,

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma
Schuster, Stephen J; Neelapu, Sattva S; Gause, Barry L; Janik, John E; Muggia, Franco M; Gockerman, Jon P; Winter, Jane N; Flowers, Christopher R; Nikcevich, Daniel A; Sotomayor, Eduardo M; McGaughey, Dean S; Jaffe, Elaine S; Chong, Elise A; Reynolds, Craig W; Berry, Donald A; Santos, Carlos F; Popa, Mihaela A; McCord, Amy M; Kwak, Larry W
2011 Jul;29(20):2787-2794, Journal of clinical oncology
— id: 161283, year: 2011, vol: 29, page: 2787, stat: Journal Article,

The regulation of MASPIN expression in epithelial ovarian cancer: Association with p53 status, and MASPIN promoter methylation: A Gynecologic Oncology Group study
Secord, Angeles Alvarez; Darcy, Kathleen M.; Hutson, Alan; Huang, Zhiqing; Lee, Paula S.; Jewell, Elizabeth L.; Havrilesky, Laura J.; Markman, Maurie; Muggia, Franco; Murphy, Susan K.
2011 NOV ;123(2):314-319, Gynecologic oncology
— id: 141784, year: 2011, vol: 123, page: 314, stat: Journal Article,

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention
Szebeni, Janos; Muggia, Franco; Gabizon, Alberto; Barenholz, Yechezkel
2011 Sep;63(12):1020-1030, Advanced drug delivery reviews
— id: 161224, year: 2011, vol: 63, page: 1020, stat: Journal Article,

Endocrine-responsive breast cancer: a 28-year Odyssey
West, A; Friedman, Kp; Muggia, F
2011 ;5:237-237, ecancermedicalscience
— id: 150577, year: 2011, vol: 5, page: 237, stat: Journal Article,

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
Adams, Sylvia; Chakravarthy, A Bapsi; Donach, Martin; Spicer, Darcy; Lymberis, Stella; Singh, Baljit; Bauer, Joshua A; Hochman, Tsivia; Goldberg, Judith D; Muggia, Franco; Schneider, Robert J; Pietenpol, Jennifer A; Formenti, Silvia C
2010 Dec;124(3):723-732, Breast cancer research & treatment
— id: 114178, year: 2010, vol: 124, page: 723, stat: Journal Article,

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
Blank, Stephanie V; Christos, Paul; Curtin, John P; Goldman, Noah; Runowicz, Carolyn D; Sparano, Joseph A; Liebes, Leonard; Chen, Helen X; Muggia, Franco M
2010 Dec;119(3):451-456, Gynecologic oncology
— id: 114176, year: 2010, vol: 119, page: 451, stat: Journal Article,

Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion
Jhaveri, A; Muggia, F
2010 ;4:182-182, ecancermedicalscience
— id: 161228, year: 2010, vol: 4, page: 182, stat: Journal Article,

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study
Kuo, Dennis Yi-Shin; Blank, Stephanie V; Christos, Paul J; Kim, Mimi; Caputo, Thomas A; Pothuri, Bhavana; Hershman, Dawn; Goldman, Noah; Ivy, Percy S; Runowicz, Carolyn D; Muggia, Franco; Goldberg, Gary L; Einstein, Mark H
2010 Mar;116(3):442-446, Gynecologic oncology
— id: 133469, year: 2010, vol: 116, page: 442, stat: Journal Article,

Tolerability of long-term use of trabectedin in combination with pegylated liposomal doxorubicin (PLD) in patients (pts) with relapsed ovarian cancer (ROC)
Meerpohl H.-G.; Romero I.; Colombo N.; Arranz J.A.; Zintl P.; Muggia F.; Tanovic A.; Santabarbara P.
2010 ;282:S204-S205, Archives of gynecology & obstetrics
— id: 114212, year: 2010, vol: 282, page: S204, stat: Journal Article,

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer
Monk, Bradley J; Herzog, Thomas J; Kaye, Stanley B; Krasner, Carolyn N; Vermorken, Jan B; Muggia, Franco M; Pujade-Lauraine, Eric; Lisyanskaya, Alla S; Makhson, Anatoly N; Rolski, Janusz; Gorbounova, Vera A; Ghatage, Prafull; Bidzinski, Mariusz; Shen, Keng; Ngan, Hextan Yuen-Sheung; Vergote, Ignace B; Nam, Joo-Hyun; Park, Youn Choi; Lebedinsky, Claudia A; Poveda, Andres M
2010 Jul;28(19):3107-3114, Journal of clinical oncology
— id: 161285, year: 2010, vol: 28, page: 3107, stat: Journal Article,

A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma
Ott, Patrick A; Hamilton, Anne; Jones, Amanda; Haas, Naomi; Shore, Tsiporah; Liddell, Sandra; Christos, Paul J; Doyle, L Austin; Millward, Michael; Muggia, Franco M; Pavlick, Anna C
2010 ;5(1):e8714-e8714, PLoS one
— id: 106468, year: 2010, vol: 5, page: e8714, stat: Journal Article,

Imatinib mesylate with weekly paclitaxel, a feasible regimen for treatment of recurrent epithelial ovarian cancer (rEOC)
Safra, T; Levinson, B; Pothuri, J; Hope, J; Curtin, J; Andreopoulou, E; Muggia, F
2010 20 May 2010;28(15):-, Journal of clinical oncology
— id: 600692, year: 2010, vol: 28, page: , stat: Journal Article,

Weekly Paclitaxel with intermittent imatinib mesylate (gleevec(r)>): tolerance and activity in recurrent epithelial ovarian cancer
Safra, Tamar; Andreopoulou, Eleni; Levinson, Benjamin; Borgato, Lucia; Pothuri, Bhavana; Blank, Stephanie; Tiersten, Amy; Boyd, Leslie; Curtin, John; Muggia, Franco
2010 Sep;30(9):3243-3247, Anticancer research
— id: 113816, year: 2010, vol: 30, page: 3243, stat: Journal Article,

Phase II Study of Liposomal Cisplatin (SPI-77) in Platinum-sensitive Recurrences of Ovarian Cancer
Seetharamu, N; Kim, E; Hochster, H; Martin, F; Muggia, F
2010 Feb;30(2):541-545, Anticancer research
— id: 108804, year: 2010, vol: 30, page: 541, stat: Journal Article,

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study
Tiersten, Amy D; Sill, Michael W; Knight, Danielle; Muggia, Franco; Garcia, Agustin A; Swensen, Ron; Warshal, David P; Mannel, Robert S; Fracasso, Paula M
2010 Sep;118(3):303-307, Gynecologic oncology
— id: 111685, year: 2010, vol: 118, page: 303, stat: Journal Article,

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma
Wu, Jennifer; Henderson, Charles; Feun, Lynn; Van Veldhuizen, Peter; Gold, Philip; Zheng, Hui; Ryan, Theresa; Blaszkowsky, Lawrence S; Chen, Haobin; Costa, Max; Rosenzweig, Barry; Nierodzik, MaryLynn; Hochster, Howard; Muggia, Franco; Abbadessa, Giovanni; Lewis, Jonathan; Zhu, Andrew X
2010 Oct;28(5):670-676, Investigational new drugs
— id: 138148, year: 2010, vol: 28, page: 670, stat: Journal Article,

Platinum compounds and radiation
Baer L; Muggia F; Formenti S
Platinum and other heavy metal compounds in cancer chemotherapy : molecular mechanisms and clinical applications New York : Humana Press, 2009,
— id: 5323, year: 2009, vol: , page: 211, stat: Chapter,

Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development
Fasano, J; Muggia, F
2009 Apr;20(4):609-614, Annals of oncology
— id: 161230, year: 2009, vol: 20, page: 609, stat: Journal Article,

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium study
Kuo, DY; Blank, SV; Kim, M; Caputo, TA; Pothuri, B; Hershman, D; Goldman, NA; Ivy, P; Runowicz, CD; Muggia, F; Goldberg, GL; Einstein, MH
2009 FEB ;112(2):S15-S15, Gynecologic oncology
— id: 97668, year: 2009, vol: 112, page: S15, stat: Journal Article,

The utility of TRC093; A humanized monoclonal antibody directed against cleaved collagen in the detection of patients at risk of ovarian and breast cancer
Liebes L.; Lu J.; Pennell R.; Blank S.; Pua T.; Muggia F.; Fishman D.; Theuer C.; Roth J.; Brooks P.
2009 ;8(12 SUPPL 1):?-?, Molecular cancer therapeutics
— id: 112583, year: 2009, vol: 8, page: ?, stat: Journal Article,

BRCA-deficient animal models and cisplatin resistance
Muggia, F
2009 May;20(5):962-962, Annals of oncology
— id: 161229, year: 2009, vol: 20, page: 962, stat: Journal Article,

Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer
Muggia, Franco
2009 Jan;112(1):275-281, Gynecologic oncology
— id: 111649, year: 2009, vol: 112, page: 275, stat: Journal Article,

Heidelberger symposium on the 50th anniversary of fluoropyrimidines
Muggia, Franco M
2009 May;8(5):991-991, Molecular cancer therapeutics
— id: 121317, year: 2009, vol: 8, page: 991, stat: Journal Article,

XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on September 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center
Muggia, Franco M; Peters, Godefridus J; Landolph, Joseph R Jr
2009 May;8(5):992-999, Molecular cancer therapeutics
— id: 121318, year: 2009, vol: 8, page: 992, stat: Journal Article,

Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma
Ott, Patrick A; Chang, Jason L; Oratz, Ruth; Jones, Amanda; Farrell, Kathleen; Muggia, Franco; Pavlick, Anna C
2009 ;55(4):221-227, Chemotherapy
— id: 100608, year: 2009, vol: 55, page: 221, stat: Journal Article,

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors
Pavlick, Anna C; Wu, Jennifer; Roberts, John; Rosenthal, Mark A; Hamilton, Anne; Wadler, Scott; Farrell, Kathleen; Carr, Michelle; Fry, David; Murgo, Anthony J; Oratz, Ruth; Hochster, Howard; Liebes, Leonard; Muggia, Franco
2009 Sep;64(4):803-810, Cancer chemotherapy & pharmacology
— id: 97002, year: 2009, vol: 64, page: 803, stat: Journal Article,

Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results
Schuster, SJ; Neelapu, SS; Gause, BL; Muggia, FM; Gockerman, JP; Sotomayor, EM; Winter, JN; Flowers, CR; Stergiou, AM; Kwak, LW
2009 JUN 20 ;27(18):-, Journal of clinical oncology
— id: 109136, year: 2009, vol: 27, page: , stat: Journal Article,

A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer
Smith, J; Baer, L; Blank, S; Dilawari, A; Carapetyan, K; Alvear, M; Utate, M; Curtin, J; Muggia, F
2009 ;3:123-123, ecancermedicalscience
— id: 161231, year: 2009, vol: 3, page: 123, stat: Journal Article,

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study
Tian, Chunqiao; Markman, Maurie; Zaino, Richard; Ozols, Robert F; McGuire, William P; Muggia, Franco M; Rose, Peter G; Spriggs, David; Armstrong, Deborah K
2009 Feb 4;115(7):1395-1403, Cancer
— id: 95534, year: 2009, vol: 115, page: 1395, stat: Journal Article,

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma : a Gynecologic Oncology Group study
Zorn, Kristin K; Tian, Chunqiao; McGuire, William P; Hoskins, William J; Markman, Maurie; Muggia, Franco M; Rose, Peter G; Ozols, Robert F; Spriggs, David; Armstrong, Deborah K
2009 Mar 1;115(5):1028-1035, Cancer
— id: 95535, year: 2009, vol: 115, page: 1028, stat: Journal Article,

Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study
Addeo, Daniela; Blank, Stephanie; Muggia, Franco; Formenti, Silvia
2008 Sep-Oct;28(5B):3143-3146, Anticancer research
— id: 93551, year: 2008, vol: 28, page: 3143, stat: Journal Article,

Pharmacodynamics of tubulin and tubulin-binding agents: extending their potential beyond taxanes
Andreopoulou, Eleni; Muggia, Franco
2008 Mar;8 Suppl 2:S54-S60, Clinical breast cancer
— id: 133615, year: 2008, vol: 8 Suppl 2, page: S54, stat: Journal Article,

Brain metastases from choriocarcinoma: two patients illustrating key management issues
Chen, T; Ginosar, D; Fink, M; Chen, A; Cieplinski, W; Curtin, J; Muggia, F M
2008 Jun;20(3):405-407, Journal of chemotherapy
— id: 161286, year: 2008, vol: 20, page: 405, stat: Journal Article,

Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers
Dilawari, A; Cangiarella, J; Smith, J; Huang, A; Downey, A; Muggia, F
2008 ;2:109-109, ecancermedicalscience
— id: 150575, year: 2008, vol: 2, page: 109, stat: Journal Article,

Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone
Goel, S; Goldberg, G L; Kuo, D Y-S; Muggia, F; Arezzo, J; Mani, S
2008 Dec;19(12):2048-2052, Annals of oncology
— id: 161232, year: 2008, vol: 19, page: 2048, stat: Journal Article,

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
Hochster, Howard; Chen, Thomas T; Lu, Janice M; Hills, Day; Sorich, Joan; Escalon, Juliet; Ivy, Percy; Liebes, Leonard; Muggia, Franco
2008 Mar;108(3):500-504, Gynecologic oncology
— id: 76389, year: 2008, vol: 108, page: 500, stat: Journal Article,

Documentation of complete response in metastatic breast cancer to liver and bone achieved with trastuzumab and pegylated liposomal Doxorubicin
Kobrinsky, Boris; Andreopoulou, Eleni; Mourtzikos, Karen; Muggia, Franco
2008 ;2:469-470, Clinical medicine. Oncology
— id: 161233, year: 2008, vol: 2, page: 469, stat: Journal Article,

A RANDOMIZED PHASE III STUDY OF TRABECTEDIN WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VERSUS PLD IN RELAPSED, RECURRENT OVARIAN CANCER (OC)
Monk, BJ; Herzog, T; Kaye, S; Krasner, CN; Vermorken, J; Muggia, F; Pujade-Lourraine, E; Renshaw, FG; Lebedinsky, C; Poveda, A
2008 SEP ;19(1):2-2, Annals of oncology
— id: 98115, year: 2008, vol: 19, page: 2, stat: Journal Article,

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study
Winter, William E 3rd; Maxwell, G Larry; Tian, Chunqiao; Sundborg, Michael J; Rose, G Scott; Rose, Peter G; Rubin, Stephen C; Muggia, Franco; McGuire, William P
2008 Jan 1;26(1):83-89, Journal of clinical oncology
— id: 135338, year: 2008, vol: 26, page: 83, stat: Journal Article,

Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo
Yuan, Y; Orlow, Sj; Curtin, J; Downey, A; Muggia, F
2008 ;2:111-111, ecancermedicalscience
— id: 150576, year: 2008, vol: 2, page: 111, stat: Journal Article,

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer
Andreopoulou, E; Gaiotti, D; Kim, E; Downey, A; Mirchandani, D; Hamilton, A; Jacobs, Allan; Curtin, John; Muggia, F
2007 Apr;18(4):716-721, Annals of oncology
— id: 72988, year: 2007, vol: 18, page: 716, stat: Journal Article,

Mucinous cancer of the appendix: challenges in diagnosis and treatment
Andreopoulou, E; Yee, H; Warycha, M A; Macari, M; Berman, R; Lowy, A; Muggia, F
2007 Aug;19(4):451-454, Journal of chemotherapy
— id: 73927, year: 2007, vol: 19, page: 451, stat: Journal Article,

Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer
Andreopoulou, Eleni; Gaiotti, Darci; Kim, Eugene; Volm, Matthew; Oratz, Ruth; Freedberg, Robin; Downey, Andrea; Vogel, Charles L; Chia, Stephen; Muggia, Franco
2007 Aug;7(9):690-696, Clinical breast cancer
— id: 75388, year: 2007, vol: 7, page: 690, stat: Journal Article,

Intraperitoneal(IP) 5'-fluoro-2'deoxyuridine(FUDR): Safety and outcome when administered prior to adjuvant chemoradiotherapy(chemoRT) following R0 resection for gastric adenocarcinoma
Cohen DJ; Ryan T; Newman E; Iqbal S; Liu M; Utate M; Moore S; Potmesil M; Hochster H; Muggia FM
2007 ;25(18S Suppl):4627-4627, Journal of clinical oncology
— id: 75186, year: 2007, vol: 25, page: 4627, stat: Journal Article,

Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone
Mani, S; McDaid, H M; Grossman, A; Muggia, F; Goel, S; Griffin, T; Colevas, D; Horwitz, S B; Egorin, M J
2007 Jan;18(1):190-195, Annals of oncology
— id: 161237, year: 2007, vol: 18, page: 190, stat: Journal Article,

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial
Morgan, R J Jr; Synold, T W; Gandara, D; Muggia, F; Scudder, S; Reed, E; Margolin, K; Raschko, J; Leong, L; Shibata, S; Tetef, M; Vasilev, S; McGonigle, K; Longmate, J; Yen, Y; Chow, W; Somlo, G; Carroll, M; Doroshow, J H
2007 Mar-Apr;17(2):373-378, International journal of gynecological cancer
— id: 161236, year: 2007, vol: 17, page: 373, stat: Journal Article,

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies
Seiden, M V; Burris, H A; Matulonis, U; Hall, J B; Armstrong, D K; Speyer, J; Weber, J D A; Muggia, F
2007 Mar;104(3):727-731, Gynecologic oncology
— id: 161235, year: 2007, vol: 104, page: 727, stat: Journal Article,

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study
Winter, William E 3rd; Maxwell, G Larry; Tian, Chunqiao; Carlson, Jay W; Ozols, Robert F; Rose, Peter G; Markman, Maurie; Armstrong, Deborah K; Muggia, Franco; McGuire, William P
2007 Aug;25(24):3621-3627, Journal of clinical oncology
— id: 161234, year: 2007, vol: 25, page: 3621, stat: Journal Article,

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer
Alberts, D S; Markman, M; Muggia, F; Ozols, R F; Eldermire, E; Bookman, M A; Chen, T; Curtin, J; Hess, L M; Liebes, L; Young, R C; Trimble, E
2006 Dec;103(3):783-792, Gynecologic oncology
— id: 161238, year: 2006, vol: 103, page: 783, stat: Journal Article,

Report of first-stage accrual for NCI 5886, a phase II study of erlotinib, carboplatin and paclitaxel as first-line treatment of ovarian cancer
Blank, SV; Curtin, JP; Goldman, NA; Runowicz, CD; Speyer, JL; Tiersten, AD; Dancey, J; Wadler, S; Muggia, FM
2006 JUN 20 ;24(18):274S-274S, Journal of clinical oncology
— id: 69299, year: 2006, vol: 24, page: 274S, stat: Journal Article,

Phase I dose-escalating study of bi-weekly pemetrexed (MTA) with fixed dose rate gemcitabine (gem) in patients with advanced cancer
Chen, AL; Ryan, T; Muggia, F; Chachoua, A; Escalon, J; Moore, S; Haniff, F; Levinson, B; Nicol, S; Hochster, H
2006 JUN 20 ;24(18):91S-91S, Journal of clinical oncology
— id: 69296, year: 2006, vol: 24, page: 91S, stat: Journal Article,

Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective
Grann, Victor R; Muggia, Franco M
2006 May 3;98(9):570-571, Journal of the National Cancer Institute
— id: 95536, year: 2006, vol: 98, page: 570, stat: Journal Article,

A risky business: Implementing a platinum-based desensitization protocol in the outpatient setting
Green, R; Downey, A; McCaffrey, K; Fusco, E; Muggia, F
2006 MAR ;33(2):437-438, Oncology nursing forum
— id: 63780, year: 2006, vol: 33, page: 437, stat: Journal Article,

Preventing intraperitoneal port (abdominal mediport) related complications: Efficacy of evidence-based treatment guidelines
Green, R; Downey, A; McCaffrey, K; Fusco, E; Muggia, F
2006 MAR ;33(2):434-435, Oncology nursing forum
— id: 63779, year: 2006, vol: 33, page: 434, stat: Journal Article,

Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study
Hochster, Howard S; Plimack, Elizabeth R; Mandeli, John; Wadler, Scott; Runowicz, Carolyn; Goldberg, Gary; Speyer, James; Wallach, Robert; Muggia, Franco
2006 Feb;100(2):324-329, Gynecologic oncology
— id: 62741, year: 2006, vol: 100, page: 324, stat: Journal Article,

Phase I study of bortezomib and oxaliplatin (BOX) in solid tumors : improved neurotoxicity (NT) profile with lower bortezomib (B) dose
Kosloff, RA; Wright, J; Ivy, P; Escalon, J; Norwood, B; Levinson, B; Pavlick, A; Beric, A; Muggia, FM; Hochster, H
2006 June 2006;24(18S):?-? #12007, Journal of clinical oncology
— id: 601302, year: 2006, vol: 24, page: ?, stat: Journal Article,

More on intraperitoneal therapy
Muggia, Franco
2006 Nov;103(2):763-763, Gynecologic oncology
— id: 161239, year: 2006, vol: 103, page: 763, stat: Journal Article,

New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment
Muggia, Franco M
2006 Dec;33(6 Suppl 12):S18-S24, Seminars in oncology
— id: 71924, year: 2006, vol: 33, page: S18, stat: Journal Article,

Topotecan continuous infusion: CA-125 responses including patients pretreated with other schedules of topotecan
Muggia, Franco; Kosloff, Rebecca; Liebes, Leonard; Hochster, Howard
2006 May;11(5):529-31; author reply 531, Oncologist
— id: 69425, year: 2006, vol: 11, page: 529, stat: Journal Article,

Association of low P27 with loss of hormone receptors in small (T1a/b) breast cancers
Wu, J; Mirchandani, D; Smith, JA; Inghirami, G; Roses, D; Zeleniuch-Jacquotte, A; Muggia, F
2006 JUN 20 ;24(18):33S-33S, Journal of clinical oncology
— id: 69294, year: 2006, vol: 24, page: 33S, stat: Journal Article,

Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer
Blank, Stephanie V; Chang, Richard; Muggia, Franco
2005 Apr;19(4):87-98, Oncology
— id: 55979, year: 2005, vol: 19, page: 87, stat: Journal Article,

Tolerability of carboplatin, paclitaxel and erlotinib as first-line treatment of ovarian cancer
Blank, SV; Curtin, JP; Goldman, NA; Fusco, E; Lesko, Z; Hochster, H; Runowicz, CD; Wadler, S; Muggia, FM
2005 JUN 1 ;23(16):467S-467S, Journal of clinical oncology
— id: 57798, year: 2005, vol: 23, page: 467S, stat: Journal Article,

A phase I study of continuous intravenous infusion (CIV) low-dose topotecan (T) combined with thoracic radiotherapy (RT)
Chandra, A; Chang, R; Steinfeld, A; Chachoua, A; Muggia, F; Formenti, S; Hochster, H
2005 ;63(2):2314-2314, International journal of radiation oncology biology physics
— id: 109248, year: 2005, vol: 63, page: 2314, stat: Journal Article,

A phase I study of oxaliplatin (OX) in combination with bortezomib (B) in patients with advanced malignancy
Chang, R; Beric, A; Liebes, LF; Wright, J; Ivy, P; Norwood, B; Escalon, J; Muggia, FM; Hochster, HS
2005 JUN 1 ;23(16):880S-880S, Journal of clinical oncology
— id: 57806, year: 2005, vol: 23, page: 880S, stat: Journal Article,

Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle
Hamilton, A L; Eder, J P; Pavlick, A C; Clark, J W; Liebes, L; Garcia-Carbonero, R; Chachoua, A; Ryan, D P; Soma, V; Farrell, K; Kinchla, N; Boyden, J; Yee, H; Zeleniuch-Jacquotte, A; Wright, J; Elliott, P; Adams, J; Muggia, F M
2005 Sep 1;23(25):6107-6116, Journal of clinical oncology
— id: 57888, year: 2005, vol: 23, page: 6107, stat: Journal Article,

Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer
Mirchandani, Deepu; Hochster, Howard; Hamilton, Anne; Liebes, Leonard; Yee, Herman; Curtin, John P; Lee, Sang; Sorich, Joan; Dellenbaugh, Cornelia; Muggia, Franco M
2005 Aug 15;11(16):5912-5919, Clinical cancer research
— id: 61253, year: 2005, vol: 11, page: 5912, stat: Journal Article,

Dialogues in oncology. Section editor's note
Muggia F
2005 ;10(5):323-4 May, Oncologist
— id: 64773, year: 2005, vol: 10, page: 323, stat: Journal Article,

Ezra Greenspan,
Muggia, F
2005 FEB ;10(2):170-171, Oncologist
— id: 48735, year: 2005, vol: 10, page: 170, stat: Journal Article,

Modern management of recurrent ovarian carcinoma - A systematic approach to a chronic disease - The Michener/Belinson article reviewed
Muggia, FM; Blank, SV
2005 SEP ;19(10):1288-+, Oncology
— id: 64628, year: 2005, vol: 19, page: 1288, stat: Journal Article,

Ezra Greenspan: a trailblazer in combination chemotherapy
Muggia, Franco
2005 ;23(1):1-2, Cancer investigation
— id: 161241, year: 2005, vol: 23, page: 1, stat: Journal Article,

Phase 1 clinical trials in oncology
Muggia, Franco M
2005 Jun 9;352(23):2451-3; author reply 2451, New England journal of medicine
— id: 95537, year: 2005, vol: 352, page: 2451, stat: Journal Article,

Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study
Muggia, Franco M; Blessing, John A; Waggoner, Steven; Berek, Jonathan S; Monk, Bradley J; Sorosky, Joel; Pearl, Michael L
2005 Jan;96(1):108-111, Gynecologic oncology
— id: 48109, year: 2005, vol: 96, page: 108, stat: Journal Article,

Investigational agents for epithelial ovarian cancer
Muggia, Franco; Kosloff, Rebecca
2005 Oct;5(5):855-868, Expert review of anticancer therapy
— id: 111739, year: 2005, vol: 5, page: 855, stat: Journal Article,

ACCO: ASCO core curriculum outline
Muss, Hyman B; Von Roenn, Jamie; Damon, Lloyd Earl; Deangelis, Lisa Marie; Flaherty, Lawrence E; Harari, Paul M; Kelly, Karen; Kosty, Michael P; Loscalzo, Matthew J; Mennel, Robert; Mitchell, Beverly S; Mortimer, Joanne E; Muggia, Franco; Perez, Edith A; Pisters, Peter W T; Saltz, Leonard; Schapira, Lidia; Sparano, Joseph
2005 Mar;23(9):2049-2077, Journal of clinical oncology
— id: 161240, year: 2005, vol: 23, page: 2049, stat: Journal Article,

Postoperative intraperitoneal (IP) 5'-fluoro-2'-deoxyuridine (FUDR) added to chemoradiation in patients curatively resected (RO) for locally advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma
Newman, E; Chang, RY; Potmesil, M; Donahue, B; Marcus, SG; Hiotis, SP; Iqbal, S; Ryan, T; Hochster, HS; Muggia, FM
2005 JUN 1 ;23(16):348S-348S, Journal of clinical oncology
— id: 57796, year: 2005, vol: 23, page: 348S, stat: Journal Article,

Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study
Newman, Elliot; Potmesil, Milan; Ryan, Theresa; Marcus, Stuart; Hiotis, Spiros; Yee, Herman; Norwood, Brendan; Wendell, Marc; Muggia, Franco; Hochster, Howard
2005 Dec;32(6 Suppl 9):S97-100, Seminars in oncology
— id: 62748, year: 2005, vol: 32, page: S97, stat: Journal Article,

Sequential phase II studies for endometrial cancer (EC): Pegylated liposomal doxorubicin (LD) with either paclitaxel (P) or docetaxel (D)
Szmulewitz, RZ; Chang, RY; Blank, SV; Curtin, JP; Hochster, HS; Hamilton, AL; Hornreich, G; Muggia, FM
2005 JUN 1 ;23(16):487S-487S, Journal of clinical oncology
— id: 57799, year: 2005, vol: 23, page: 487S, stat: Journal Article,

Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials
Alberts, David S; Muggia, Franco M; Carmichael, James; Winer, Eric P; Jahanzeb, Mohammad; Venook, Alan P; Skubitz, Keith M; Rivera, Edgardo; Sparano, Joseph A; DiBella, Nicholas J; Stewart, Simon J; Kavanagh, John J; Gabizon, Alberto A
2004 Dec;31(6 Suppl 13):53-90, Seminars in oncology
— id: 95539, year: 2004, vol: 31, page: 53, stat: Journal Article,

Risk assessment in non-Ashkenazi women attending a cancer risk assessment clinic
Blank, SV; Smith, JA; Carapetyan, KJ; Utate, MA; Muggia, FM; Curtin, JP
2004 JUL 15 ;22(14):550S-550S, Journal of clinical oncology
— id: 48685, year: 2004, vol: 22, page: 550S, stat: Journal Article,

Epothilone B analog (BMS-247550) at the recommended phase II dose (R
Chen, T; Molina, A; Moore, S; Goel, S; Desai, K; Hamilton, A; Griffin, T; Colevas, AD; Mani, S; Muggia, F
2004 JUL 15 ;22(14):155S-155S, Journal of clinical oncology
— id: 48676, year: 2004, vol: 22, page: 155S, stat: Journal Article,

Thalidomide (Thal) tolerance in patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
Goldenberg, A; Volm, M; Hochster, H; Muggia, F; Rosen, R; Teperman, L; Morgan, G; Schwartz, J; Sung, M; Wadler, S
2004 JUL 15 ;22(14):376S-376S, Journal of clinical oncology
— id: 48682, year: 2004, vol: 22, page: 376S, stat: Journal Article,

Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group
Hochster, Howard; Plimack, Elizabeth R; Runowicz, Carolyn D; Speyer, James; Wallach, Robert C; Sorich, Joan; Mandeli, John; Wadler, Scott; Wright, John; Muggia, Franco M
2004 Jan 1;22(1):120-126, Journal of clinical oncology
— id: 42292, year: 2004, vol: 22, page: 120, stat: Journal Article,

A phase I study of carboplatin plus oral topotecan in advanced malignancies
Kim, E; Hochster, H; Novik, Y; Chachoua, A; Speyer, J; Muggia, F
2004 JUL 15 ;22(14):161S-161S, Journal of clinical oncology
— id: 48677, year: 2004, vol: 22, page: 161S, stat: Journal Article,

Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors
Mani, Sridhar; McDaid, Hayley; Hamilton, Anne; Hochster, Howard; Cohen, Marvin B; Khabelle, Dineo; Griffin, Tom; Lebwohl, David E; Liebes, Leonard; Muggia, Franco; Horwitz, Susan Band
2004 Feb 15;10(4):1289-1298, Clinical cancer research
— id: 44739, year: 2004, vol: 10, page: 1289, stat: Journal Article,

Liposomal anthracycline treatment for ovarian cancer
Markman, Maurie; Gordon, Alan N; McGuire, William P; Muggia, Franco M
2004 Dec;31(6 Suppl 13):91-105, Seminars in oncology
— id: 95538, year: 2004, vol: 31, page: 91, stat: Journal Article,

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer
Morgan, Robert J Jr; Synold, Timothy W; Gandara, David; Muggia, Franco; Scudder, Sidney; Reed, Eddie; Margolin, Kim; Raschko, James; Leong, Lucille; Shibata, Stephen; Tetef, Merry; Vasilev, Steven; McGonigle, Kathryn; Longmate, Jeff; Yen, Yun; Chow, Warren; Somlo, George; Carroll, Mary; Doroshow, James H
2004 Oct;54(4):283-289, Cancer chemotherapy & pharmacology
— id: 44817, year: 2004, vol: 54, page: 283, stat: Journal Article,

'Retarded pharmaceuticals' assuming a clinical role
Muggia, F M
2004 Oct;27(5):437-438, Onkologie
— id: 161287, year: 2004, vol: 27, page: 437, stat: Journal Article,

Platinums: extending their therapeutic spectrum
Muggia, F M; Fojo, T
2004 Nov;16 Suppl 4:77-82, Journal of chemotherapy
— id: 50633, year: 2004, vol: 16 Suppl 4, page: 77, stat: Journal Article,

Safety of prolonged Doxil administration in recurrent gynecologic cancers
Muggia, F; Kim, E; Downey, A; McCaffrey, K; Green, R; Ho, MF; Mirchandani, D; Sorich, J; Hochster, H; Hamilton, A
2004 JUL 15 ;22(14):462S-462S, Journal of clinical oncology
— id: 48684, year: 2004, vol: 22, page: 462S, stat: Journal Article,

Re: 'Radiation recall dermatitis induced by pegylated liposomal doxorubicin'
Muggia, Franco M
2004 Jan;15(1):35-35, Anti-cancer drugs
— id: 44818, year: 2004, vol: 15, page: 35, stat: Journal Article,

Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers
Muggia, Franco M
2004 Dec;31(6 Suppl 14):17-24, Seminars in oncology
— id: 48889, year: 2004, vol: 31, page: 17, stat: Journal Article,

Relevance of chemotherapy dose and schedule to outcomes in ovarian cancer
Muggia, Franco M
2004 Dec;31(6 Suppl 15):19-24, Seminars in oncology
— id: 48890, year: 2004, vol: 31, page: 19, stat: Journal Article,

The emerging roles of screening and prevention in women's cancer
Muggia, Franco M
2004 ;9(2):228-231, Oncologist
— id: 44819, year: 2004, vol: 9, page: 228, stat: Journal Article,

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
Muggia, Franco M; Blessing, John A; McGehee, Ramon; Monk, Bradley J
2004 Aug;94(2):483-487, Gynecologic oncology
— id: 44815, year: 2004, vol: 94, page: 483, stat: Journal Article,

Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
Muggia, Franco M; Blessing, John A; Method, Michael; Miller, David Scott; Johnson, Gary A; Lee, Roger B; Menzin, Andrew
2004 Feb;92(2):639-643, Gynecologic oncology
— id: 42595, year: 2004, vol: 92, page: 639, stat: Journal Article,

Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study
Nezhat, Farr; Wadler, Scott; Muggia, Franco; Mandeli, John; Goldberg, Gary; Rahaman, Jamal; Runowicz, Carolyn; Murgo, Anthony J; Gardner, Ginger J
2004 Apr;93(1):144-148, Gynecologic oncology
— id: 44821, year: 2004, vol: 93, page: 144, stat: Journal Article,

Familial breast cancer screening: ethical and social implications
Paradiso, A; Muggia, F
2004 ;15 Suppl 1(2):I5-I6, Annals of oncology
— id: 44816, year: 2004, vol: 15 Suppl 1, page: I5, stat: Journal Article,

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor
Pavlick, Anna C; Chodkiewicz, Catherine; Liebes, Leonard; Hamilton, Anne; Wasserheit, Carolyn; Hochster, Howard; Speyer, James; Phillips, Zoe; Downey, Andrea; Sorich, Joan; Muggia, Franco
2004 Feb;15(2):119-125, Anti-cancer drugs
— id: 44738, year: 2004, vol: 15, page: 119, stat: Journal Article,

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer
Seiden, Michael V; Muggia, Franco; Astrow, Allan; Matulonis, Ursula; Campos, Susanna; Roche, Maria; Sivret, Julia; Rusk, Jason; Barrett, Emma
2004 Apr;93(1):229-232, Gynecologic oncology
— id: 44820, year: 2004, vol: 93, page: 229, stat: Journal Article,

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions
Chanan-Khan, A; Szebeni, J; Savay, S; Liebes, L; Rafique, N M; Alving, C R; Muggia, F M
2003 Sep;14(9):1430-1437, Annals of oncology
— id: 44752, year: 2003, vol: 14, page: 1430, stat: Journal Article,

Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial
Formenti, Silvia C; Volm, Matthew; Skinner, Kristin A; Spicer, Darcy; Cohen, Deidre; Perez, Edith; Bettini, Anna C; Groshen, Susan; Gee, Conway; Florentine, Barbara; Press, Michael; Danenberg, Peter; Muggia, Franco
2003 Mar 1;21(5):864-870, Journal of clinical oncology
— id: 34943, year: 2003, vol: 21, page: 864, stat: Journal Article,

Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors
Goel, S; Bulgaru, A; Hochster, H; Wadler, S; Zamboni, W; Egorin, M; Ivy, P; Leibes, L; Muggia, F; Lockwood, G; Harvey, E; Renshaw, G; Mani, S
2003 Nov;14(11):1682-1687, Annals of oncology
— id: 44740, year: 2003, vol: 14, page: 1682, stat: Journal Article,

Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies
Haigentz, Missak Jr; Kim, Mimi; Sorich, Joan; Lee, Janet; Hochster, Howard; Macapinlac, Manuel; Mirchandani, Deepu; Sewak, Sanjeev; Pavlick, Anna; Volm, Matthew; Hamilton, Anne; Muggia, Franco M
2003 Apr;14(4):321-326, Anti-cancer drugs
— id: 44744, year: 2003, vol: 14, page: 321, stat: Journal Article,

Pegylated liposomal doxorubicin (PLD) and carboplatin (C): A phase I study of combination therapy with maintenance PLD
Hamilton AL; Pavlick A; Volm M; Adams S; Hochster H; Moore S; Mozina J; Cordner M; Utate M; Muggia F
2003 ;22:2003-2003 #1986, Proceedings (American Society of Clinical Oncology)
— id: 79467, year: 2003, vol: 22, page: 2003, stat: Journal Article,

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer
Hochster, Howard; Chachoua, Abraham; Speyer, James; Escalon, Juliette; Zeleniuch-Jacquotte, Anne; Muggia, Franco
2003 Jul 15;21(14):2703-2707, Journal of clinical oncology
— id: 44743, year: 2003, vol: 21, page: 2703, stat: Journal Article,

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines
Ling, Yi-He; Liebes, Leonard; Jiang, Jian-Dong; Holland, James F; Elliott, Peter J; Adams, Julian; Muggia, Franco M; Perez-Soler, Roman
2003 Mar;9(3):1145-1154, Clinical cancer research
— id: 44754, year: 2003, vol: 9, page: 1145, stat: Journal Article,

Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy
Lu, M Janice; Sorich, Joan; Hazarika, Maitreyee; Kim, Mimi; Del Priore, Giuseppe; Jacobs, Allan J; Chiang, Chang; Liu, Paul C; Fusco, Eileen; Curtin, John P; Muggia, Franco M
2003 Aug;17(4):969-975, Hematology-oncology clinics of North America
— id: 39088, year: 2003, vol: 17, page: 969, stat: Journal Article,

Sequential single agents as first-line chemotherapy for ovarian cancer: a strategy derived from the results of GOG-132
Muggia, F M
2003 Nov-Dec;13 Suppl 2(1):156-162, International journal of gynecological cancer
— id: 44823, year: 2003, vol: 13 Suppl 2, page: 156, stat: Journal Article,

Doxorubicin for metastatic breast cancer: time for a change?
Muggia, Franco
2003 ;21(6):967-968, Cancer investigation
— id: 44822, year: 2003, vol: 21, page: 967, stat: Journal Article,

Boosting bioavailability to topotecan: what do we gain?
Muggia, Franco M
2003 Jan;21(1):177; author reply 177-177; author reply 177 177; author reply 177, Journal of clinical oncology
— id: 161288, year: 2003, vol: 21, page: 177; author reply 177, stat: Journal Article,

Treatment of sarcomas: thinking out-of-the-box
Muggia, Franco M; Pavlick, Anna
2003 Apr;21(2):321-322, Cancer investigation
— id: 44824, year: 2003, vol: 21, page: 321, stat: Journal Article,

Emerging treatments for ovarian cancer
Muggia, Franco; Lu, M Janice
2003 May;8(1):203-216, Expert opinion on emerging drugs
— id: 38999, year: 2003, vol: 8, page: 203, stat: Journal Article,

Vaccine therapy of follicular lymphoma in first remission: Long-term follow-up of phase II results and high rate of chemotherapy-induced complete remissions in a controlled, randomized phase III trial
Neelapu, SS; Gause, BL; Nikcevich, DA; Schuster, SJ; Winter, J; Gockerman, JP; Sotomayor, E; Inghirami, G; Muggia, F; Watson, T; Snow, S; Kubovic, P; Ferraro, M; Jaffe, ES; Reynolds, CW; Kwak, LW
2003 NOV 16 ;102(11):307B-308B, Blood
— id: 42519, year: 2003, vol: 102, page: 307B, stat: Journal Article,

A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting
Sewak, Sanjeev; Chachoua, Abraham; Hamilton, Anne; Taneja, Samir; Lee, Janet; Utate, Minerva; Sorich, Joan; Muggia, Franco M
2003 Jan;14(1):67-72, Anti-cancer drugs
— id: 34609, year: 2003, vol: 14, page: 67, stat: Journal Article,

A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893)
Skeel, Roland T; Huang, Jie; Manola, Judith; Wilding, George; Dreicer, Robert; Walker, Paul; Muggia, Franco; Crawford, E David; Dutcher, Janice P; Loehrer, Patrick J
2003 ;21(1):41-46, Cancer investigation
— id: 161242, year: 2003, vol: 21, page: 41, stat: Journal Article,

Liposome-induced hypersensitivity reactions: The role of complement activation
Szebeni, J; Baranyi, L; Savay, S; Milosevits, J; Bunger, R; Laverman, P; Metselaar, JM; Storm, G; Chanan-Khan, A; Liebes, L; Muggia, FM; Cohen, R; Barenholz, Y; Alving, CR
2003 AUG 7 ;13(1):47-48, Journal of liposome research
— id: 37173, year: 2003, vol: 13, page: 47, stat: Journal Article,

Complement activation underlying pseudoallergic drug reactions
Szebeni, J; Baranyi, L; Savay, S; Milosevits, J; Chanan-Khan, AA; Liebes, L; Muggia, FM; Barenholz, Y; Bunger, R; Alving, CR
2003 SEP ;40(2-4):180-180, Molecular immunology
— id: 55475, year: 2003, vol: 40, page: 180, stat: Journal Article,

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!
Alberts, David S; Markman, Maurie; Armstrong, Deborah; Rothenberg, Mace L; Muggia, Franco; Howell, Stephen B
2002 Oct;20(19):3944-3946, Journal of clinical oncology
— id: 161243, year: 2002, vol: 20, page: 3944, stat: Journal Article,

Pre-clinical studies of concomitant PS-341 and ionizing radiation therapy: local and systemic anti-tumor effects
Formenti, S; Demaria, S; Liebes, L; Ng, B; Devitt, M; Babbs, J; Muggia, F
2002 NOV ;38(4):34-A256, European journal of cancer (1990)
— id: 98237, year: 2002, vol: 38, page: 34, stat: Journal Article,

Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study
Hawes, Debra; Liu, P Y; Muggia, Franco M; Wilczynski, Sharon; Cote, Richard; Felix, Juan; Terada, Keith; Belt, Robert J; Alberts, David S
2002 Oct;87(1):17-23, Gynecologic oncology
— id: 161289, year: 2002, vol: 87, page: 17, stat: Journal Article,

Use of medroxyprogesterone acetate in the treatment of Mullerian adenosarcoma: a case report
Hines, Brian J; Porges, Robert F; Mittal, Kush; Muggia, Franco M; Curtin, John P
2002 Apr;85(1):192-195, Gynecologic oncology
— id: 36624, year: 2002, vol: 85, page: 192, stat: Journal Article,

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis
Ling, Yi-He; Liebes, Leonard; Ng, Bruce; Buckley, Michael; Elliott, Peter J; Adams, Julian; Jiang, Jian-Dong; Muggia, Franco M; Perez-Soler, Roman
2002 Aug;1(10):841-849, Molecular cancer therapeutics
— id: 44756, year: 2002, vol: 1, page: 841, stat: Journal Article,

Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study
McDaid, Hayley M; Mani, Sridhar; Shen, Heng-Jia; Muggia, Franco; Sonnichsen, Daryl; Horwitz, Susan Band
2002 Jul;8(7):2035-2043, Clinical cancer research
— id: 161244, year: 2002, vol: 8, page: 2035, stat: Journal Article,

Current data with liposomal anthracyclines in metatastic breast cancer
Muggia F; Formenti SC; Volm M
2002 Aug;1(1):11-14, Current trends in anthracyclines
— id: 109306, year: 2002, vol: 1, page: 11, stat: Journal Article,

Stable disease in mesothelioma: a therapeutic achievement?
Muggia, Franco
2002 ;20(5-6):859-860, Cancer investigation
— id: 161245, year: 2002, vol: 20, page: 859, stat: Journal Article,

Thoughts about September 11, 2001: civilization's resilience and tenacity
Muggia, Franco M
2002 ;7(1):87-87, Oncologist
— id: 161290, year: 2002, vol: 7, page: 87, stat: Journal Article,

Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study
Muggia, Franco M; Blessing, John A; Sorosky, Joel; Reid, Gary C
2002 May 1;20(9):2360-2364, Journal of clinical oncology
— id: 27563, year: 2002, vol: 20, page: 2360, stat: Journal Article,

Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days
Muggia, Franco M; Liebes, Leonard; Hazarika, Maitreyee; Wadler, Scott; Hamilton, Anne; Hornreich, Gila; Sorich, Joan; Chiang, Chung; Newman, Elliot; Potmesil, Milan; Hochster, Howard
2002 Sep;13(8):819-825, Anti-cancer drugs
— id: 39386, year: 2002, vol: 13, page: 819, stat: Journal Article,

Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer
Newman, Elliot; Marcus, Stuart G; Potmesil, Milan; Sewak, Sanjeev; Yee, Herman; Sorich, Joan; Hayek, Mary; Muggia, Franco; Hochster, Howard
2002 Mar-Apr;6(2):212-23; discussion 223, Journal of gastrointestinal surgery
— id: 39653, year: 2002, vol: 6, page: 212, stat: Journal Article,

Thalidomide in hepatocellular cancer (HCC) with optional interferon-alpha upon progression
Schwartz JD; Sung MW; Lehrer D; Goldenberg A; Muggia F; Volm M
2002 ;21:- #1847, Proceedings (American Society of Clinical Oncology)
— id: 92760, year: 2002, vol: 21, page: , stat: Journal Article,

Endometrial carcinoma with cerebellar metastasis: a case report and review of the literature
Sewak, Sanjeev; Muggia, Franco M; Zagzag, David
2002 Jun;58(2):137-140, Journal of neuro-oncology
— id: 34739, year: 2002, vol: 58, page: 137, stat: Journal Article,

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies
Szebeni, J; Baranyi, L; Savay, S; Milosevits, J; Bunger, R; Laverman, P; Metselaar, J M; Storm, G; Chanan-Khan, A; Liebes, L; Muggia, F M; Cohen, R; Barenholz, Y; Alving, C R
2002 Feb-May;12(1-2):165-172, Journal of liposome research
— id: 44755, year: 2002, vol: 12, page: 165, stat: Journal Article,

Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy
Demaria S; Volm MD; Shapiro RL; Yee HT; Oratz R; Formenti SC; Muggia F; Symmans WF
2001 Oct;7(10):3025-3030, Clinical cancer research
— id: 24141, year: 2001, vol: 7, page: 3025, stat: Journal Article,

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma
Ferrari AC; Chachoua A; Singh H; Rosenthal M; Taneja S; Bednar M; Mandeli J; Muggia F
2001 Jun 1;91(11):2039-2045, Cancer
— id: 34610, year: 2001, vol: 91, page: 2039, stat: Journal Article,

Clinical course of locally advanced breast cancer (LABC) patients with pathological response to primary concurrent 5-fluorouracil and radiation (FU/RT)
Formenti, S. C.; Cohen, D.; Tsao-Wei, D. D.; Muggia, F. M.
2001 ;51(3 Supplement 1):195-196, International journal of radiation oncology biology physics
— id: 109249, year: 2001, vol: 51, page: 195, stat: Journal Article,

Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorin
Garcia, A A; Muggia, F M; Spears, C P; Jeffers, S; Silberman, H; Pujari, M; Koda, R T
2001 Jul;12(6):505-511, Anti-cancer drugs
— id: 161291, year: 2001, vol: 12, page: 505, stat: Journal Article,

Estramustine potentiates taxane in prostate and refractory breast cancers
Hamilton A; Muggia F
2001 May;15(5 Suppl 7):40-43, Oncology
— id: 20620, year: 2001, vol: 15, page: 40, stat: Journal Article,

Inhibition of H-ras membrane binding and topoisomerase-1 in a phase I trial of topotecan combined with the farnesyl transferase inhibitor, R115777 (Zarnestra)
Hochster, H; Liebes, L; Buckley, M; Sorich, J; Fry, D; Hamilton, A; Wright, J; Muggia, F
2001 NOV ;7(11):3710S-3710S, Clinical cancer research
— id: 54797, year: 2001, vol: 7, page: 3710S, stat: Journal Article,

Doxil-induced radiation recall: a cause for false-positive PET scan findings
Hornreich, G; Schloss, C; Hoskins, W J; Muggia, F M
2001 Mar;80(3):422-423, Gynecologic oncology
— id: 161292, year: 2001, vol: 80, page: 422, stat: Journal Article,

A unique combination effect on cytotoxic activity is observed with H460 cells following sequential administration of the proteasome inhibitor, PS-341 and the chemopreventative agent, 2-phenethyl isothiocyanate (PEITC)
Mendoza, S; Ng, B; Hamilton, A; Elliott, PJ; Muggia, F; Liebes, L
2001 NOV ;7(11):3750S-3750S, Clinical cancer research
— id: 54798, year: 2001, vol: 7, page: 3750S, stat: Journal Article,

Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
Mirchandani, D; Muggia, F
2001 Sep;93(18):1420-1; author reply 1421, Journal of the National Cancer Institute
— id: 161246, year: 2001, vol: 93, page: 1420, stat: Journal Article,

Low p27 in T1N0M0 breast cancers - association with other unfavorable molecular markers of prognosis
Mirchandani, D; Tang, T; Inghirami, G; Roses, D; Shapiro, R; Harris, M; Muggia, F
2001 WIN ;69(3):337-119, Breast cancer research & treatment
— id: 98269, year: 2001, vol: 69, page: 337, stat: Journal Article,

Chemoradiation for patients with cervical cancer
Muggia F; Formenti SC; Curtin J
Progress in oncology 2001 Boston MA : Jones & Bartlett, 2001,
— id: 5316, year: 2001, vol: , page: 168, stat: Chapter,

Liposomal encapsulated anthracyclines: new therapeutic horizons
Muggia FM
2001 Mar;3(2):156-162, Current oncology reports
— id: 26786, year: 2001, vol: 3, page: 156, stat: Journal Article,

Phase III data on Caelyx in ovarian cancer
Muggia, F; Hamilton, A
2001 Dec;37 Suppl 9:S15-S18, European journal of cancer (1990)
— id: 111710, year: 2001, vol: 37 Suppl 9, page: S15, stat: Journal Article,

CPT-11/cisplatin neoadjuvant therapy downstages locally advanced gastric cancer
Newman, E; Marcus, SG; Potmesil, M; Hochster, H; Yee, H; Sewak, S; Hayek, M; Muggia, FM
2001 APR ;120(5):A129-A129, Gastroenterology
— id: 55029, year: 2001, vol: 120, page: A129, stat: Journal Article,

Increased breast cancer tumor localization and enhanced cytotoxicity of radioimmunotherapy and chemotherapy combinations
Ng, B; Kramer, E; Ceriani, R; Volm, M; Hamilton, A; Muggia, F; Formenti, S; Furmanski, P; Liebes, L
2001 ;69(3):303-303 #527, Breast cancer research & treatment
— id: 109250, year: 2001, vol: 69, page: 303, stat: Journal Article,

Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome
Safra, T; Groshen, S; Jeffers, S; Tsao-Wei, D D; Zhou, L; Muderspach, L; Roman, L; Morrow, C P; Burnett, A; Muggia, F M
2001 Jan;91(1):90-100, Cancer
— id: 161293, year: 2001, vol: 91, page: 90, stat: Journal Article,

Serial fine needle aspirations during neoadjuvant chemotherapy: Assessment of apoptotic responses in breast cancer
Symmans, W. F.; Volm, M.; Shapiro, R. L.; Demaria, S.; Yee, H.; Formenti, S. C.; Muggia, F.
2001 ;8(Supplement 1):S46-S46, International journal of molecular medicine
— id: 109251, year: 2001, vol: 8, page: S46, stat: Journal Article,

Increase in the lymphocytic infiltrate in breast cancer after neoadjuvant paclitaxel chemotherapy
Demaria, Sandra; Volm, M. D.; Shapiro, R. L.; Yee, H. T.; Oratz, R.; Formenti, S.; Muggia, F.; Symmans, W. F.
2000 ;43(41):334-334, Proceedings (American Association for Cancer Research)
— id: 109238, year: 2000, vol: 43, page: 334, stat: Journal Article,

Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study
Fleming, G F; Roth, B J; Baker, S D; Sutton, G P; Look, K Y; Muggia, F M; Fracasso, P M; McGuire, W P 3rd
2000 Dec;23(6):609-613, American journal of clinical oncology
— id: 161294, year: 2000, vol: 23, page: 609, stat: Journal Article,

Proteasome inhibition by PS-341: A phase I study
Hamilton, A; Eder, JP; Pavlick, A; Clark, JW; Chachoua, A; Ryan, DP; Farrell, K; Wasserstrom, H; Liebes, L; Wright, J; Elliott, P; Adams, J; Muggia, F
2000 NOV ;6(6):4549S-4549S, Clinical cancer research
— id: 54445, year: 2000, vol: 6, page: 4549S, stat: Journal Article,

Phase II study of liposomal doxorubicin in advanced gynecologic cancers
Israel, V P; Garcia, A A; Roman, L; Muderspach, L; Burnett, A; Jeffers, S; Muggia, F M
2000 Aug;78(2):143-147, Gynecologic oncology
— id: 161295, year: 2000, vol: 78, page: 143, stat: Journal Article,

BRCA1 germline mutation presenting as an adenocarcinoma of unknown primary
Klein, P; Prolla, G; Wallach, R; Melamed, J; Muggia, F M
2000 May-Jun;6(3):188-190, Cancer journal
— id: 161297, year: 2000, vol: 6, page: 188, stat: Journal Article,

Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial
Moinpour, C M; Sawyers Triplett, J; McKnight, B; Lovato, L C; Upchurch, C; Leichman, C G; Muggia, F M; Tanaka, L; James, W A; Lennard, M; Meyskens, F L Jr
2000 Jul-Aug;9(4):340-354, Psycho-oncology
— id: 161296, year: 2000, vol: 9, page: 340, stat: Journal Article,

Intraperitoneal topoisomerase-I inhibitors. Preliminary findings with 9-aminocamptothecin
Muggia F; Liebes L; Potmesil M; Hamilton A; Hochster H; Hornreich G; Sorich J; Downey A; Wasserstrom H
2000 ;922(1):178-187, Annals of the New York Academy of Sciences
— id: 39489, year: 2000, vol: 922, page: 178, stat: Journal Article,

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study [see comments]
Muggia FM; Braly PS; Brady MF; Sutton G; Niemann TH; Lentz SL; Alvarez RD; Kucera PR; Small JM
2000 Jan;18(1):106-115, Journal of clinical oncology
— id: 11877, year: 2000, vol: 18, page: 106, stat: Journal Article,

Modulation of taxanes in breast cancer
Muggia, Franco M; Hamilton, Anne
2000 Nov 03-06;18(SUPPL. 1):64-66, Cancer investigation
— id: 15829, year: 2000, vol: 18, page: 64, stat: Journal Article,

Maintenance chemotherapy in advanced ovarian cancer
Piver, M S; Muggia, F M; Brady, M F; Alvarez, R
2000 Apr;18(8):1803-1805, Journal of clinical oncology
— id: 161298, year: 2000, vol: 18, page: 1803, stat: Journal Article,

Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme
Rosenthal MA; Gruber ML; Glass J; Nirenberg A; Finlay J; Hochster H; Muggia FM
2000 Mar;47(1):59-63, Journal of neuro-oncology
— id: 36034, year: 2000, vol: 47, page: 59, stat: Journal Article,

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
Safra, T; Muggia, F; Jeffers, S; Tsao-Wei, D D; Groshen, S; Lyass, O; Henderson, R; Berry, G; Gabizon, A
2000 Aug;11(8):1029-1033, Annals of oncology
— id: 161247, year: 2000, vol: 11, page: 1029, stat: Journal Article,

Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment
Symmans WF; Volm MD; Shapiro RL; Perkins AB; Kim AY; Demaria S; Yee HT; McMullen H; Oratz R; Klein P; Formenti SC; Muggia F
2000 Dec;6(12):4610-4617, Clinical cancer research
— id: 22642, year: 2000, vol: 6, page: 4610, stat: Journal Article,

Primary paclitaxel in breast cancer: Does beta-tubulin predict pathologic response?
Formenti, SC; Muggia, FM; Volm, M; Danenberg, K; Danenberg, PV
1999 FEB ;26(1):35-35, Seminars in oncology
— id: 98325, year: 1999, vol: 26, page: 35, stat: Journal Article,

Twice-weekly paclitaxel and radiation therapy in locally advanced breast cancer: Clinical and pathological response
Formenti, SC; Skinner, K; Spicer, D; Muggia, F; Danenberg, K; Danenberg, P
1999 ;26(6):6-6, Seminars in oncology
— id: 109224, year: 1999, vol: 26, page: 6, stat: Journal Article,

Paclitaxel and radiation therapy in locally advanced breast cancer: Preliminary clinical results
Formenti, SC; Symmans, F; Volm, M; Skinner, K; Perez, E; Muggia, F
1999 FEB ;26(1):29-29, Seminars in oncology
— id: 98324, year: 1999, vol: 26, page: 29, stat: Journal Article,

Clinical pharmacodynamics of topoisomerase-1 inhibitor therapy: lessons and issues for future studies
Hochster, H; Liebes, L; Wadler, S; Runowicz, C; Potmesil, M; Speyer, J; Muggia, F
1999 NOV ;5(4):3775S-3776S, Clinical cancer research
— id: 53799, year: 1999, vol: 5, page: 3775S, stat: Journal Article,

Cytoprotection: shelter from the storm
Klein P; Muggia FM
1999 ;4(2):112-121, Oncologist
— id: 56438, year: 1999, vol: 4, page: 112, stat: Journal Article,

Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors
Koda, R T; Garcia, A A; Chatterjee, D J; Li, W Y; Parimoo, D; Jeffers, S; Rogers, M; Leichman, C G; Leichman, L; Wu, E Y; Shetty, B V; Webber, S; Clendinnin, N; Muggia, F M
1999 ;43(6):489-496, Cancer chemotherapy & pharmacology
— id: 161299, year: 1999, vol: 43, page: 489, stat: Journal Article,

Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention
Muggia FM
1999 Jan;5(1):7-8, Clinical cancer research
— id: 57058, year: 1999, vol: 5, page: 7, stat: Journal Article,

Doxorubicin-induced cardiomyopathy
Muggia FM; Speyer JL
1999 Feb 25;340(8):654-655, New England journal of medicine
— id: 57059, year: 1999, vol: 340, page: 654, stat: Journal Article,

MDR1 gene expression in primary and advanced breast cancer
Yang, X; Uziely, B; Groshen, S; Lukas, J; Israel, V; Russell, C; Dunnington, G; Formenti, S; Muggia, F; Press, M F
1999 Mar;79(3):271-280, Laboratory investigation
— id: 109139, year: 1999, vol: 79, page: 271, stat: Journal Article,

Concurrent paclitaxel and radiation in locally advanced breast cancer
Formenti, C; Skinner, S; Spicer, K; Cohen, D; Kutsch, D; Symmans, K; Volm, F; Muggia, FM
1998 SEP ;34(11):S12-S12, European journal of cancer (1990)
— id: 53659, year: 1998, vol: 34, page: S12, stat: Journal Article,

Molecular determinants of response of locally advanced breast cancer to 5-FU and radiation
Formenti, Silvia; Park, Ji Min; Salonga, Dennis; Williams-Hill, Donna; Danenberg, Kathleen; Muggia, Franco; Danenberg, Peter V.
1998 ;39(41):187-187, Proceedings (American Association for Cancer Research)
— id: 109243, year: 1998, vol: 39, page: 187, stat: Journal Article,

Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors
Garcia AA; Keren-Rosenberg S; Parimoo D; Rogers M; Jeffers S; Koda R; Muggia FM
1998 Sep;16(9):2959-2963, Journal of clinical oncology
— id: 7575, year: 1998, vol: 16, page: 2959, stat: Journal Article,

A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas
Garcia, A A; Kempf, R A; Rogers, M; Muggia, F M
1998 Oct;9(10):1131-1133, Annals of oncology
— id: 161300, year: 1998, vol: 9, page: 1131, stat: Journal Article,

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
Lara, P N Jr; Gandara, D R; Wurz, G T; Lau, D; Uhrich, M; Turrell, C; Raschko, J; Edelman, M J; Synold, T; Doroshow, J; Muggia, F; Perez, E A; DeGregorio, M
1998 ;42(6):504-508, Cancer chemotherapy & pharmacology
— id: 161248, year: 1998, vol: 42, page: 504, stat: Journal Article,

Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group
Muggia FM; Blessing JA; Homesley HD; Sorosky J
1998 ;42(1):68-70, Cancer chemotherapy & pharmacology
— id: 57344, year: 1998, vol: 42, page: 68, stat: Journal Article,

Doxil in breast cancer
Muggia, F M
1998 Feb;16(2):811-812, Journal of clinical oncology
— id: 161304, year: 1998, vol: 16, page: 811, stat: Journal Article,

Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?
Muggia, F M; Conti, P S
1998 Aug;9(8):924-924, Annals of oncology
— id: 161302, year: 1998, vol: 9, page: 924, stat: Journal Article,

Camptothecins: a review of their development and schedules of administration
O'Leary J; Muggia FM
1998 Sep;34(10):1500-1508, European journal of cancer (1990)
— id: 57221, year: 1998, vol: 34, page: 1500, stat: Journal Article,

Taxanes in adjuvant and neoadjuvant therapies for breast cancer
O'Leary J; Volm M; Wasserheit C; Muggia F
1998 Jan;12(1 Suppl 1):23-27, Oncology
— id: 7722, year: 1998, vol: 12, page: 23, stat: Journal Article,

Anti-angiogenic effects of 9-amino-20(S)-camptothecin (9AC), topotecan (TTN), and camptosar (C
O'Leary, JJ; Shapiro, RL; Ren, CJ; Chuang, N; Cohen, HW; Muggia, F; Potmesil, M
1998 AUG 25 ;9(4):78-78, Annals of oncology
— id: 53386, year: 1998, vol: 9, page: 78, stat: Journal Article,

Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer
Safra T; Jeffers S; Sorich J; Muggia FM
1998 Jul;9(6):511-514, Anti-cancer drugs
— id: 57243, year: 1998, vol: 9, page: 511, stat: Journal Article,

Cellular but not plasma pharmacokinetics of lometrexol correlate with the occurrence of cumulative hematological toxicity
Synold, T W; Newman, E M; Carroll, M; Muggia, F M; Groshen, S; Johnson, K; Doroshow, J H
1998 Oct;4(10):2349-2355, Clinical cancer research
— id: 161301, year: 1998, vol: 4, page: 2349, stat: Journal Article,

Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study
Szebeni, J; Muggia, F M; Alving, C R
1998 Feb;90(4):300-306, Journal of the National Cancer Institute
— id: 161303, year: 1998, vol: 90, page: 300, stat: Journal Article,

Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy
Formenti SC; Dunnington G; Uzieli B; Lenz H; Keren-Rosenberg S; Silberman H; Spicer D; Denk M; Leichman G; Groshen S; Watkins K; Muggia F; Florentine B; Press M; Danenberg K; Danenberg P
1997 Dec 1;39(5):1059-1068, International journal of radiation oncology biology physics
— id: 34954, year: 1997, vol: 39, page: 1059, stat: Journal Article,

Tolerance of paclitaxel 3-hour infusion with and without granulocyte colony-stimulating factor on a biweekly schedule
Garcia AA; Parimoo D; Dimery I; Rogers M; Jeffers S; Muggia FM
1997 Dec;24(6 Suppl 19):S19-S62, Seminars in oncology
— id: 7574, year: 1997, vol: 24, page: S19, stat: Journal Article,

Activity of anthracyclines in refractory ovarian cancer: recent experience and review
Garcia, A; Muggia, F M
1997 ;15(4):329-334, Cancer investigation
— id: 133226, year: 1997, vol: 15, page: 329, stat: Journal Article,

Response to estramustine phosphate and paclitaxel in patients with advanced breast cancer: a phase I study
Keren-Rosenberg, S; Muggia, F M
1997 Feb;24(1 Suppl 3):S26-S29, Seminars in oncology
— id: 161308, year: 1997, vol: 24, page: S26, stat: Journal Article,

Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study
Muderspach LI; Curtin JP; Roman LD; Gebhardt JA; Klement V; Qian D; Morrow CP; Felix JC; Formenti SC; Muggia FM
1997 May;65(2):336-342, Gynecologic oncology
— id: 34956, year: 1997, vol: 65, page: 336, stat: Journal Article,

Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers
Muggia FM
1997 ;54 Suppl 4:22-29, Drugs
— id: 56974, year: 1997, vol: 54 Suppl 4, page: 22, stat: Journal Article,

Salvage treatment of ovarian cancer
Muggia, F M
1997 Nov;15(11):3420-3421, Journal of clinical oncology
— id: 161305, year: 1997, vol: 15, page: 3420, stat: Journal Article,

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation
Muggia, F M; Hainsworth, J D; Jeffers, S; Miller, P; Groshen, S; Tan, M; Roman, L; Uziely, B; Muderspach, L; Garcia, A; Burnett, A; Greco, F A; Morrow, C P; Paradiso, L J; Liang, L J
1997 Mar;15(3):987-993, Journal of clinical oncology
— id: 111689, year: 1997, vol: 15, page: 987, stat: Journal Article,

Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin)
Muggia, F M; Jeffers, S; Muderspach, L; Roman, L; Rosales, R; Groshen, S; Safra, T; Morrow, C P
1997 Aug;66(2):290-294, Gynecologic oncology
— id: 161306, year: 1997, vol: 66, page: 290, stat: Journal Article,

Severe neurotoxicity in vinorelbine-paclitaxel combinations - Response
Muggia, FM
1997 JAN 1 ;89(1):88-88, Journal of the National Cancer Institute
— id: 53369, year: 1997, vol: 89, page: 88, stat: Journal Article,

Determination of hydroxyurea in plasma and peritoneal fluid by high-performance liquid chromatography using electrochemical detection
Pujari, M P; Barrientos, A; Muggia, F M; Koda, R T
1997 Jun;694(1):185-191, Journal of chromatography. B. Biomedical sciences & applications
— id: 161307, year: 1997, vol: 694, page: 185, stat: Journal Article,

MDR1 gene expression in primary and advanced breast cancer
Yang, X.; Uziely, B.; Groshen, S.; Lukas, J.; Israel, V.; Russell, C.; Dunnington, G.; Formenti, S.; Muggia, F.; Press, M. F.
1997 ;38(0):389-389, Proceedings (American Association for Cancer Research)
— id: 109244, year: 1997, vol: 38, page: 389, stat: Journal Article,

High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults
Douer, D; Levine, A; Anderson, W F; Gordon, M; Groshen, S; Khan, A; Mohrbacher, A; Muggia, F; Shibata, D
1996 Mar;7(5):669-684, Human gene therapy
— id: 161251, year: 1996, vol: 7, page: 669, stat: Journal Article,

Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology
Formenti SC; Shrivastava PN; Sapozink M; Jozsef G; Chan KK; Jeffers S; Morrow PC; Muggia FM
1996 Jul 15;35(5):993-1001, International journal of radiation oncology biology physics
— id: 34957, year: 1996, vol: 35, page: 993, stat: Journal Article,

Saline MR peritoneography
Magre, G R; Terk, M; Colletti, P; Muggia, F; Boswell, W
1996 Sep;167(3):749-751, American journal of roentgenology (1976)
— id: 161249, year: 1996, vol: 167, page: 749, stat: Journal Article,

Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies
Markman, M; Homesley, H; Norberts, D A; Schink, J; Abbas, F; Miller, A; Soper, J; Teng, N; Hammond, N; Muggia, F; Israel, M; Sweatman, T
1996 Apr;61(1):90-93, Gynecologic oncology
— id: 161250, year: 1996, vol: 61, page: 90, stat: Journal Article,

Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues
Muderspach, L; Muggia, F M; Conti, P S
1996 Nov;21(6):499-511, Cancer treatment reviews
— id: 161310, year: 1996, vol: 21, page: 499, stat: Journal Article,

Dose intensity: not the only path to clinical dose optimization
Muggia, F M
1996 Spring;6(2):57-58, Journal of infusional chemotherapy
— id: 161316, year: 1996, vol: 6, page: 57, stat: Journal Article,

Camptothecin and its analogs. An overview of their potential in cancer therapeutics
Muggia, F M; Dimery, I; Arbuck, S G
1996 Dec;803:213-223, Annals of the New York Academy of Sciences
— id: 161309, year: 1996, vol: 803, page: 213, stat: Journal Article,

Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology Group
Muggia, F M; Liu, P Y; Alberts, D S; Wallace, D L; O'Toole, R V; Terada, K Y; Franklin, E W; Herrer, G W; Goldberg, D A; Hannigan, E V
1996 Jun;61(3):395-402, Gynecologic oncology
— id: 161315, year: 1996, vol: 61, page: 395, stat: Journal Article,

Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexol
Muggia, F M; Synold, T W; Newman, E M; Jeffers, S; Leichman, L P; Doroshow, J H; Johnson, K; Groshen, S
1996 Oct;88(20):1495-1496, Journal of the National Cancer Institute
— id: 161311, year: 1996, vol: 88, page: 1495, stat: Journal Article,

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil
Muggia, F M; Wu, X; Spicer, D; Groshen, S; Jeffers, S; Leichman, C G; Leichman, L; Chan, K K
1996 Sep;2(9):1461-1467, Clinical cancer research
— id: 161312, year: 1996, vol: 2, page: 1461, stat: Journal Article,

Severe neurotoxicity from vinorelbine-paclitaxel combinations
Parimoo, D; Jeffers, S; Muggia, F M
1996 Aug;88(15):1079-1080, Journal of the National Cancer Institute
— id: 161314, year: 1996, vol: 88, page: 1079, stat: Journal Article,

Simple and sensitive method for the quantitative analysis of lometrexol in plasma using high-performance liquid chromatography with electrochemical detection
Synold, T W; Xi, B; Newman, E M; Muggia, F M; Doroshow, J H
1996 Aug;683(2):245-249, Journal of chromatography. B, Biomedical applications
— id: 161313, year: 1996, vol: 683, page: 245, stat: Journal Article,

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin
Gill, P S; Espina, B M; Muggia, F; Cabriales, S; Tulpule, A; Esplin, J A; Liebman, H A; Forssen, E; Ross, M E; Levine, A M
1995 Apr;13(4):996-1003, Journal of clinical oncology
— id: 161253, year: 1995, vol: 13, page: 996, stat: Journal Article,

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study
Israel, V K; Jiang, C; Muggia, F M; Tulpule, A; Jeffers, S; Leichman, L; Morrow, C P; Roman, L; Leichman, C G; Chan, K K
1995 ;37(1-2):32-38, Cancer chemotherapy & pharmacology
— id: 161322, year: 1995, vol: 37, page: 32, stat: Journal Article,

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study
Leichman, C G; Fleming, T R; Muggia, F M; Tangen, C M; Ardalan, B; Doroshow, J H; Meyers, F J; Holcombe, R F; Weiss, G R; Mangalik, A
1995 Jun;13(6):1303-1311, Journal of clinical oncology
— id: 161320, year: 1995, vol: 13, page: 1303, stat: Journal Article,

High-performance liquid chromatographic method for the determination of a novel thymidylate synthase inhibitor, AG 331, in human serum
Li, W Y; Chatterjee, D J; Shetty, B V; Wu, E Y; Muggia, F; Koda, R T
1995 Nov;673(2):281-288, Journal of chromatography. B, Biomedical applications
— id: 161252, year: 1995, vol: 673, page: 281, stat: Journal Article,

A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer
Muggia, F M; Chan, K K
1995 Jun;75(11):2782-2782, Cancer
— id: 161319, year: 1995, vol: 75, page: 2782, stat: Journal Article,

Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials
Muggia, F M; Vafai, D; Natale, R; Israel, V; Zaretsky, S; McRae, A; Rogers, M; Jeffers, S
1995 Aug;22(4 Suppl 9):63-66, Seminars in oncology
— id: 161317, year: 1995, vol: 22, page: 63, stat: Journal Article,

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer
Saltz, L B; Leichman, C G; Young, C W; Muggia, F M; Conti, J A; Spiess, T; Jeffers, S; Leichman, L P
1995 Feb;75(3):782-785, Cancer
— id: 161321, year: 1995, vol: 75, page: 782, stat: Journal Article,

Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapy
Spears, C P; Carlsson, G; Muggia, F M; Jaresko, G; Gustavsson, B G
1995 ;78:115-134, Cancer treatment & research
— id: 161324, year: 1995, vol: 78, page: 115, stat: Journal Article,

Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma
Turrill, M; Spicer, D V; Kelley, A S; Herman, R L; Russell, C A; Muggia, F M
1995 ;13(2):160-164, Cancer investigation
— id: 161323, year: 1995, vol: 13, page: 160, stat: Journal Article,

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies
Uziely, B; Jeffers, S; Isacson, R; Kutsch, K; Wei-Tsao, D; Yehoshua, Z; Libson, E; Muggia, F M; Gabizon, A
1995 Jul;13(7):1777-1785, Journal of clinical oncology
— id: 161318, year: 1995, vol: 13, page: 1777, stat: Journal Article,

Amifostine protects bone marrow from platinum compounds without altering platinum-DNA adducts in buccal cells
Formenti, S. C.; Flor-Weiss, E. Dela; Gill, I.; Jeffers, S.; Blommaert, F.; Michaels, C.; Muggia, F. M.; Den Engelse, L.
1994 ;1(6):287-291, Cellular pharmacology
— id: 109223, year: 1994, vol: 1, page: 287, stat: Journal Article,

Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome)
Guaglianone, P; Chan, K; DelaFlor-Weiss, E; Hanisch, R; Jeffers, S; Sharma, D; Muggia, F
1994 ;12(2):103-110, Investigational new drugs
— id: 161257, year: 1994, vol: 12, page: 103, stat: Journal Article,

Platinum resistance. Experimental and clinical status
Los, G; Muggia, F M
1994 Apr;8(2):411-429, Hematology-oncology clinics of North America
— id: 161327, year: 1994, vol: 8, page: 411, stat: Journal Article,

Cytoprotection: concepts and challenges
Muggia, F M
1994 Nov;2(6):377-379, Supportive care in cancer
— id: 161325, year: 1994, vol: 2, page: 377, stat: Journal Article,

More on intraperitoneal therapy
Muggia, F M
1994 Sep;5(7):662-663, Annals of oncology
— id: 161326, year: 1994, vol: 5, page: 662, stat: Journal Article,

Teniposide: overview of its therapeutic potential in adult cancers
Muggia, F M
1994 ;34 Suppl:S127-S133, Cancer chemotherapy & pharmacology
— id: 161330, year: 1994, vol: 34 Suppl, page: S127, stat: Journal Article,

Clinical development of topoisomerase-interactive drugs
Muggia, F M; Burris, H A
1994 ;29B:1-31, Advances in pharmacology (New York)
— id: 161329, year: 1994, vol: 29B, page: 1, stat: Journal Article,

Platinum compounds in cervical and endometrial cancers: focus on carboplatin
Muggia, F M; Muderspach, L
1994 Apr;21(2 Suppl 2):'411'-'429', Seminars in oncology
— id: 161328, year: 1994, vol: 21, page: '411', stat: Journal Article,

Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance
Muggia, F M; Tulpule, A; Retzios, A; Chen, F; Jeffers, S; Leichman, C G; Leichman, L; Spears, C P; Chan, K K
1994 ;12(3):197-206, Investigational new drugs
— id: 161331, year: 1994, vol: 12, page: 197, stat: Journal Article,

PREFACE
MUGGIA, FM; SPEYER, JL
1994 APR ;8(2):R9-&, Hematology-oncology clinics of North America
— id: 52506, year: 1994, vol: 8, page: R9, stat: Journal Article,

Calvert's formula and high-dose carboplatin
Uziely B; Formenti SC; Watkins K; Mazumder A; Muggia FM
1994 Aug;12(8):1740-1741, Journal of clinical oncology
— id: 34962, year: 1994, vol: 12, page: 1740, stat: Journal Article,

Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications
Uziely, B; Groshen, S; Jeffers, S; Morris, M; Russell, C; Roman, L; Muderspach, L; Muggia, F
1994 Nov;5(9):827-833, Annals of oncology
— id: 161254, year: 1994, vol: 5, page: 827, stat: Journal Article,

Low doses of dexamethasone protect against paclitaxel (Taxol)-related hypersensitivity reactions following cycle 1
Uziely, B; Jeffers, S; Muggia, F
1994 May;5(5):474-474, Annals of oncology
— id: 161255, year: 1994, vol: 5, page: 474, stat: Journal Article,

Preclinical pharmacokinetics and stability of isophosphoramide mustard
Zheng, J J; Chan, K K; Muggia, F
1994 ;33(5):391-398, Cancer chemotherapy & pharmacology
— id: 161256, year: 1994, vol: 33, page: 391, stat: Journal Article,

Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response
Blommaert, F A; Michael, C; Terheggen, P M; Muggia, F M; Kortes, V; Schornagel, J H; Hart, A A; den Engelse, L
1993 Dec;53(23):5669-5675, Cancer research
— id: 161332, year: 1993, vol: 53, page: 5669, stat: Journal Article,

Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinums
DelaFlor-Weiss, E; Uziely, B; Muggia, F M
1993 Nov;4(9):723-733, Annals of oncology
— id: 161333, year: 1993, vol: 4, page: 723, stat: Journal Article,

How to improve survival after diagnosis of gastric cancer? It's back to the drawing board
Muggia, F M
1993 Aug;11(8):1437-1438, Journal of clinical oncology
— id: 161336, year: 1993, vol: 11, page: 1437, stat: Journal Article,

Management of peritoneal carcinomatosis of unknown primary tumor site
Muggia, F M; Baranda, J
1993 Jun;20(3):268-272, Seminars in oncology
— id: 161338, year: 1993, vol: 20, page: 268, stat: Journal Article,

Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens
Muggia, F M; Groshen, S; Russell, C; Jeffers, S; Chen, S C; Schlaerth, J; Curtin, J; Morrow, C P
1993 Aug;50(2):232-238, Gynecologic oncology
— id: 161335, year: 1993, vol: 50, page: 232, stat: Journal Article,

Platinum resistance: laboratory findings and clinical implications
Muggia, F M; Los, G
1993 May;11(3):182-193, Stem cells
— id: 161339, year: 1993, vol: 11, page: 182, stat: Journal Article,

Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis
Ray, M S; Muggia, F M; Leichman, C G; Grunberg, S M; Nelson, R L; Dyke, R W; Moran, R G
1993 Jul;85(14):1154-1159, Journal of the National Cancer Institute
— id: 161337, year: 1993, vol: 85, page: 1154, stat: Journal Article,

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies
Reed, E; Parker, R J; Gill, I; Bicher, A; Dabholkar, M; Vionnet, J A; Bostick-Bruton, F; Tarone, R; Muggia, F M
1993 Aug;53(16):3694-3699, Cancer research
— id: 161334, year: 1993, vol: 53, page: 3694, stat: Journal Article,

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro
Dabholkar, M; Bradshaw, L; Parker, R J; Gill, I; Bostick-Bruton, F; Muggia, F M; Reed, E
1992 Nov;98:53-59, Environmental health perspectives
— id: 161341, year: 1992, vol: 98, page: 53, stat: Journal Article,

Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program
Leichman, L; Silberman, H; Leichman, C G; Spears, C P; Ray, M; Muggia, F M; Kiyabu, M; Radin, R; Laine, L; Stain, S
1992 Dec;10(12):1933-1942, Journal of clinical oncology
— id: 161340, year: 1992, vol: 10, page: 1933, stat: Journal Article,

EFFECT OF LOCAL HYPERTHERMIA ON THE PHARMACOKINETICS PKS OF INTRAPERITONEAL IP CARBOPLATIN CB CLINICAL AND PRECLINICAL STUDY
MUGGIA F; FORMENTI S C; SAPOZINK M; CHAN K K; LOS G
1992 ;33(0):501-501, Proceedings (American Association for Cancer Research)
— id: 109245, year: 1992, vol: 33, page: 501, stat: Journal Article,

Search for the optimal treatment of ovarian cancer: heavy metals, "belly baths," and ... yew trees
Muggia, F
1992 May;10(5):683-685, Journal of clinical oncology
— id: 161259, year: 1992, vol: 10, page: 683, stat: Journal Article,

Managing breast cancer in an outpatient setting
Muggia, F M
1992 ;21(1):27-34, Breast cancer research & treatment
— id: 161350, year: 1992, vol: 21, page: 27, stat: Journal Article,

Randomized trial: another opinion
Muggia, F M
1992 Jun;3(6):492-492, Annals of oncology
— id: 161343, year: 1992, vol: 3, page: 492, stat: Journal Article,

Vitamin A intoxication during taxol therapy for refractory ovarian cancer
Muggia, F M
1992 Sep;84(18):1444-1445, Journal of the National Cancer Institute
— id: 161342, year: 1992, vol: 84, page: 1444, stat: Journal Article,

High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers
Muggia, F M; Brown, T D; Goodman, P J; Macdonald, J S; Hersh, E M; Fleming, T R; Leichman, L
1992 Jun;3(3):211-217, Anti-cancer drugs
— id: 161344, year: 1992, vol: 3, page: 211, stat: Journal Article,

Role of carboplatin in endometrial and cervical carcinomas
Muggia, F M; Gill, I
1992 Feb;19(1 Suppl 2):90-93, Seminars in oncology
— id: 161349, year: 1992, vol: 19, page: 90, stat: Journal Article,

Teniposide in adult solid tumors: a historical perspective
Muggia, F M; Kelley, S L
1992 Apr;19(2 Suppl 6):43-50, Seminars in oncology
— id: 161347, year: 1992, vol: 19, page: 43, stat: Journal Article,

Intraperitoneal therapy for ovarian cancer: analysis of fluid distribution by computerized tomography
Muggia, F M; LePoidevin, E; Jeffers, S; Russell, C; Boswell, W; Morrow, C P; Curtin, J; Schlaerth, J
1992 Feb;3(2):149-154, Annals of oncology
— id: 161348, year: 1992, vol: 3, page: 149, stat: Journal Article,

Treatment of colon cancer based on biochemical modulation of fluoropyrimidines by hydroxyurea
Muggia, F M; Moran, R G
1992 Jun;19(3 Suppl 9):90-93, Seminars in oncology
— id: 161345, year: 1992, vol: 19, page: 90, stat: Journal Article,

Hexamethylmelamine in platinum-resistant ovarian cancer: how active?
Muggia, F; Norris, K Jr
1992 Dec;47(3):279-281, Gynecologic oncology
— id: 161258, year: 1992, vol: 47, page: 279, stat: Journal Article,

No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study
Nichols, C R; Roth, B J; Williams, S D; Gill, I; Muggia, F M; Stablein, D M; Weiss, R B; Einhorn, L H
1992 May;10(5):760-765, Journal of clinical oncology
— id: 161346, year: 1992, vol: 10, page: 760, stat: Journal Article,

RADIATION-THERAPY AND FLUOROURACIL WITH OR WITHOUT SEMUSTINE FOR THE TREATMENT OF PATIENTS WITH SURGICAL ADJUVANT ADENOCARCINOMA OF THE RECTUM
WOOLLEY, PV; NAUTA, R; SMITH, FP; LINDBLAD, AS; PETRELLI, N; HERRERA, L; DOUGLASS, HO; MAYER, RJ; BRUCKNER, HW; DALTON, J; BONADONNA, G; GENNARI, L; HALL, TC; WEAVER, DW; LEICHMAN, L; KALSER, MH; BENEDETTO, P; MUGGIA, FM; GREEN, M; GREENWALD, E; LEVIN, B; GAYNOR, E; HARRIS, J; MARSH, JC; BARWICK, K; KNOWLTON, AH; LIVSTONE, EM; BUKOWSKI, RM; LOUTFI, A; RAMIREZ, G; THOMAS, PRM
1992 APR ;10(4):549-557, Journal of clinical oncology
— id: 52037, year: 1992, vol: 10, page: 549, stat: Journal Article,

High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primary
Gill, I; Guaglianone, P; Grunberg, S M; Scholz, M; Muggia, F M
1991 May-Jun;11(3):1231-1235, Anticancer research
— id: 161356, year: 1991, vol: 11, page: 1231, stat: Journal Article,

Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts
Gill, I; Muggia, F M; Terheggen, P M; Michael, C; Parker, R J; Kortes, V; Grunberg, S; Christian, M C; Reed, E; den Engelse, L
1991 Feb;2(2):115-121, Annals of oncology
— id: 161357, year: 1991, vol: 2, page: 115, stat: Journal Article,

ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies
Green MD; Alderton P; Sobol MM; Gross J; Muggia FM; Speyer JL
1991 ;58(4):101-117, Cancer treatment & research
— id: 35093, year: 1991, vol: 58, page: 101, stat: Journal Article,

Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study
Grunberg, S M; Crowley, J J; Livingston, R B; Muggia, F M; MacDonald, J S; Williamson, S K; Stephens, R L
1991 ;28(3):211-213, Cancer chemotherapy & pharmacology
— id: 161361, year: 1991, vol: 28, page: 211, stat: Journal Article,

Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience
Hersh, E M; Metch, B S; Muggia, F M; Brown, T D; Whitehead, R P; Budd, G T; Rinehart, J J; Crawford, E D; Bonnet, J D; Behrens, B C
1991 Dec;10(6):426-431, Journal of immunotherapy
— id: 161351, year: 1991, vol: 10, page: 426, stat: Journal Article,

Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study
Kish, J A; Kopecky, K; Samson, M K; Von Hoff, D D; Fletcher, W S; Kempf, R A; Muggia, F M
1991 Feb;9(1):105-108, Investigational new drugs
— id: 161358, year: 1991, vol: 9, page: 105, stat: Journal Article,

Phase II trial of carboplatin or iproplatin in cervical cancer
Lira-Puerto, V; Silva, A; Morris, M; Martinez, R; Groshen, S; Morales-Canfield, F; Tenorio, F; Muggia, F
1991 ;28(5):391-396, Cancer chemotherapy & pharmacology
— id: 161261, year: 1991, vol: 28, page: 391, stat: Journal Article,

Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study
McLeod, D G; Weiss, R B; Stablein, D M; Muggia, F M; Paulson, D F; Ellis, J H; Spaulding, J T; Donohue, J P
1991 Jun;145(6):1178-83; discussion 1182, Journal of urology
— id: 161355, year: 1991, vol: 145, page: 1178, stat: Journal Article,

Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine
Muggia FM; Chan KK; Russell C; Colombo N; Speyer JL; Sehgal K; Jeffers S; Sorich J; Leichman L; Beller U; et al
1991 ;28(4):241-250, Cancer chemotherapy & pharmacology
— id: 14203, year: 1991, vol: 28, page: 241, stat: Journal Article,

Cancer and hypercalcemia of malignancy: a change in focus
Muggia, F
1991 Aug;18(4 Suppl 5):1-2, Seminars in oncology
— id: 161260, year: 1991, vol: 18, page: 1, stat: Journal Article,

Cisplatin update
Muggia, F M
1991 Feb;18(1 Suppl 3):1-4, Seminars in oncology
— id: 161359, year: 1991, vol: 18, page: 1, stat: Journal Article,

Intraperitoneal therapy in ovarian cancer: time's not up
Muggia, F M; Alberts, D S
1991 Aug;9(8):1510-1511, Journal of clinical oncology
— id: 161353, year: 1991, vol: 9, page: 1510, stat: Journal Article,

New anthracycline antitumor antibiotics
Muggia, F M; Green, M D
1991 ;11(1):43-64, Critical reviews in oncology-hematology
— id: 161362, year: 1991, vol: 11, page: 43, stat: Journal Article,

Adjuvant therapy of colon cancer: lessons while looking for breakthroughs
Muggia, F M; Groshen, S
1991 Oct;2(9):641-644, Annals of oncology
— id: 161352, year: 1991, vol: 2, page: 641, stat: Journal Article,

New chemotherapies for ovarian cancer. Systemic and intraperitoneal podophyllotoxins
Muggia, F M; Russell, C A
1991 Jan;67(1 Suppl):225-230, Cancer
— id: 161360, year: 1991, vol: 67, page: 225, stat: Journal Article,

Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry
Parker, R J; Gill, I; Tarone, R; Vionnet, J A; Grunberg, S; Muggia, F M; Reed, E
1991 Jul;12(7):1253-1258, Carcinogenesis
— id: 161354, year: 1991, vol: 12, page: 1253, stat: Journal Article,

Plasma carcinoembryonic antigen as an indicator of cerebral metastases
Eden EA; Muggia JM; Hiesiger EM; Muggia FM
1990 Jun;8(3):281-287, Journal of neuro-oncology
— id: 21718, year: 1990, vol: 8, page: 281, stat: Journal Article,

Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529)
Green MD; Alderton P; Gross J; Muggia FM; Speyer JL
1990 ;48(1):61-69, Pharmacology & therapeutics
— id: 35095, year: 1990, vol: 48, page: 61, stat: Journal Article,

Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer
Green MD; Speyer JL; Wernz JC; Colombo N; Beller U; Muggia FM; Beckman EM
1990 Aug;8(3):333-336, Investigational new drugs
— id: 15690, year: 1990, vol: 8, page: 333, stat: Journal Article,

Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacology
Hochster H; Green M; Liebes L; Speyer JL; Wernz J; Blum R; Muggia F
1990 ;26(4):297-300, Cancer chemotherapy & pharmacology
— id: 35094, year: 1990, vol: 26, page: 297, stat: Journal Article,

Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies
Hu, E; Ko, R; Koda, R; Rosen, P; Jeffers, S; Scholtz, M; Muggia, F
1990 ;26(5):359-364, Cancer chemotherapy & pharmacology
— id: 161263, year: 1990, vol: 26, page: 359, stat: Journal Article,

Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers
Leichman, C G; Leichman, L; Spears, C P; Rosen, P J; Muggia, F; Jeffers, S; Waugh, W
1990 ;26(1):57-61, Cancer chemotherapy & pharmacology
— id: 161264, year: 1990, vol: 26, page: 57, stat: Journal Article,

We're "fossilized" in the optimal use of the Ommaya reservoir
Muggia, F
1990 Jun;4(6):74-74, Oncology
— id: 161262, year: 1990, vol: 4, page: 74, stat: Journal Article,

Monoclonal antibody therapy in intra-abdominal malignancies
Muggia, F M
1990 ;8(2):293-294, Cancer investigation
— id: 161365, year: 1990, vol: 8, page: 293, stat: Journal Article,

Overview of cancer-related hypercalcemia: epidemiology and etiology
Muggia, F M
1990 Apr;17(2 Suppl 5):3-9, Seminars in oncology
— id: 161363, year: 1990, vol: 17, page: 3, stat: Journal Article,

Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy
Speyer JL; Beller U; Colombo N; Sorich J; Wernz JC; Hochster H; Green M; Porges R; Muggia FM; Canetta R; et al
1990 Aug;8(8):1335-1341, Journal of clinical oncology
— id: 15691, year: 1990, vol: 8, page: 1335, stat: Journal Article,

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician
Von Hoff, D D; Sandbach, J F; Clark, G M; Turner, J N; Forseth, B F; Piccart, M J; Colombo, N; Muggia, F M
1990 Jan;82(2):110-116, Journal of the National Cancer Institute
— id: 161364, year: 1990, vol: 82, page: 110, stat: Journal Article,

Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS)
Chachoua A; Green M; Wernz J; Muggia F
1989 Nov;7(4):327-331, Investigational new drugs
— id: 10450, year: 1989, vol: 7, page: 327, stat: Journal Article,

Phase I/II trial of thymostimulin in opportunistic infections of the acquired immune deficiency syndrome
Chachoua A; Green MD; Valentine F; Muggia FM
1989 ;7(3):225-229, Cancer investigation
— id: 10760, year: 1989, vol: 7, page: 225, stat: Journal Article,

Progressive paresthesias after cessation of therapy with very high-dose cisplatin
Grunberg, S M; Sonka, S; Stevenson, L L; Muggia, F M
1989 ;25(1):62-64, Cancer chemotherapy & pharmacology
— id: 161370, year: 1989, vol: 25, page: 62, stat: Journal Article,

Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin
Muggia, F M
1989 Apr;16(2 Suppl 5):7-13, Seminars in oncology
— id: 161369, year: 1989, vol: 16, page: 7, stat: Journal Article,

Epipodophyllotoxins: new laboratory and clinical findings
Muggia, F M; Gill, I
1989 Dec;1(2):206-212, Current opinion in oncology
— id: 161366, year: 1989, vol: 1, page: 206, stat: Journal Article,

Future of cancer chemotherapy with cisplatin
Muggia, F M; Norris, K Jr
1989 Aug;16(4 Suppl 6):123-128, Seminars in oncology
— id: 161367, year: 1989, vol: 16, page: 123, stat: Journal Article,

Cancer chemotherapy : concepts, clinical investigations, and therapeutic advances
Muggia, Franco M
Boston MA : Kluwer, 1989,
— id: 2134, year: 1989, vol: , page: , stat: ,

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group
Petrelli, N; Douglass, H O Jr; Herrera, L; Russell, D; Stablein, D M; Bruckner, H W; Mayer, R J; Schinella, R; Green, M D; Muggia, F M
1989 Oct;7(10):1419-1426, Journal of clinical oncology
— id: 132491, year: 1989, vol: 7, page: 1419, stat: Journal Article,

Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans
Shani, J; Bertram, J; Russell, C; Dahalan, R; Chen, D C; Parti, R; Ahmadi, J; Kempf, R A; Kawada, T K; Muggia, F M
1989 Apr;49(7):1877-1881, Cancer research
— id: 161368, year: 1989, vol: 49, page: 1877, stat: Journal Article,

The disposition of carboplatin in ovarian cancer patients
Gaver RC; Colombo N; Green MD; George AM; Deeb G; Morris AD; Canetta RM; Speyer JL; Farmen RH; Muggia FM
1988 ;22(3):263-270, Cancer chemotherapy & pharmacology
— id: 35098, year: 1988, vol: 22, page: 263, stat: Journal Article,

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon
Green MD; Speyer JL; Hochster HS; Liebes LF; Dunleavy S; Widman T; Wernz JC; Blum RH; Spiegel RJ; Muggia FM
1988 May 1;48(9):2574-2578, Cancer research
— id: 11108, year: 1988, vol: 48, page: 2574, stat: Journal Article,

A new look at radionuclides therapy in metastatic disease of bone (review and prospects)
Kim, S I; Chen, D C; Muggia, F M
1988 Jul-Aug;8(4):681-684, Anticancer research
— id: 161372, year: 1988, vol: 8, page: 681, stat: Journal Article,

Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide
Krigel RL; Slywotzky CM; Lonberg M; Green MD; Andes WA; Kempf R; Gupta S; Grace W; Spiegel RJ; Muggia FM; et al.
1988 Aug;7(4):359-364, Journal of biological response modifiers
— id: 34859, year: 1988, vol: 7, page: 359, stat: Journal Article,

Radiotherapy in the treatment of ovarian dysgerminoma
Muggia, F M
1988 Oct;15(4):1050-1051, International journal of radiation oncology biology physics
— id: 161371, year: 1988, vol: 15, page: 1050, stat: Journal Article,

Toxicity comparisons between two chemotherapy regimens as adjuvant or salvage treatment in nonseminomatous testicular cancer
Weiss, R B; Stablein, D M; Muggia, F M; Einhorn, L H; Golbey, R B; DeWys, W D
1988 Jul;62(1):18-23, Cancer
— id: 161373, year: 1988, vol: 62, page: 18, stat: Journal Article,

Surgical treatment for advanced epithelial carcinoma of the ovary
Beller, U; Beckman, E M; Muggia, F M; Douglas, G W
1987 Sep;165(3):279-283, Surgery, gynecology & obstetrics
— id: 123506, year: 1987, vol: 165, page: 279, stat: Journal Article,

Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcoma
Chachoua A; Green M; Laubenstein L; Wernz J; Muggia FM
1987 Jul-Aug;71(7-8):775-776, Cancer treatment reports
— id: 14635, year: 1987, vol: 71, page: 775, stat: Journal Article,

THE DISPOSITION OF CARBOPLATIN IN OVARIAN-CANCER PATIENTS
Gaver, RC; Colombo, N; Green, MD; George, AM; Deeb, G; Morris, AD; Canetta, RM; Speyer, JL; Farmen, RH; Muggia, FM
1987 Mar;28(3):195-195, Proceedings (American Association for Cancer Research)
— id: 31224, year: 1987, vol: 28, page: 195, stat: Journal Article,

Carcinoid syndrome from a tumor of Meckel's diverticulum
Green, M; Oratz, R; Muggia, F M
1987 Jul;83(1):184-186, American journal of medicine
— id: 67940, year: 1987, vol: 83, page: 184, stat: Journal Article,

PHASE-I TRIAL AND PHARMACOKINETICS OF ORAL 4 DEMETHOXYDAUN- ORUBICIN (IDARUBICIN)
Green, MD; Hochster, H; Speyer, JL; Liebes, L; Wernz, JC; Blum, RH; Ward, C; London, C; Mendoza, S; Muggia, FM
1987 Mar;28(3):192-192, Proceedings (American Association for Cancer Research)
— id: 31223, year: 1987, vol: 28, page: 192, stat: Journal Article,

A RANDOMIZED TRIAL OF ICRF-187 TO REDUCE DOXORUBICIN (DOX) CARDIOMYOPATHY - COMPARATIVE ACUTE TOXICITIES
Green, MD; Speyer, JL; Stecy, P; Rey, M; Kramer, E; Sanger, J; Ward, C; London, C; Blum, R; Wernz, J; Rohde, J; Muggia, FM
1987 May;5(1):117-117, Investigational new drugs
— id: 31182, year: 1987, vol: 5, page: 117, stat: Journal Article,

Treatment of advanced refractory lymphoma with teniposide and lomustine
Grossberg, H; Opfell, R; Glick, J; Bakemeier, R; Schnetzer, G 3rd; Muggia, F
1987 Feb;71(2):215-216, Cancer treatment reports
— id: 161266, year: 1987, vol: 71, page: 215, stat: Journal Article,

Malignancies in the acquired immunodeficiency syndrome
Levine, A M; Gill, P S; Muggia, F
1987 Jul-Aug;11(4):209-255, Current problems in cancer
— id: 161265, year: 1987, vol: 11, page: 209, stat: Journal Article,

European Organization for Research and Treatment of Cancer Workshop. Problems and prospects in current therapeutic application of molecular biology
McVie, J G; Muggia, F M
1987 Jun;47(11):3032-3032, Cancer research
— id: 161376, year: 1987, vol: 47, page: 3032, stat: Journal Article,

Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancer
Muggia FM; Camacho FJ; Kaplan BH; Green MD; Greenwald ES; Wernz JC; Engstrom PF
1987 Mar;71(3):253-256, Cancer treatment reports
— id: 15694, year: 1987, vol: 71, page: 253, stat: Journal Article,

Closing the loop: providing feedback on drug development
Muggia, F M
1987 Jan;71(1):1-2, Cancer treatment reports
— id: 161379, year: 1987, vol: 71, page: 1, stat: Journal Article,

Treatment strategies in relation to drug action
Muggia, F M; McVie, G
1987 ;(4):129-133, NCI monographs
— id: 161380, year: 1987, vol: , page: 129, stat: Journal Article,

Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells
Muggia, F M; Slowiaczek, P; Tattersall, M H
1987 Mar-Apr;7(2):161-166, Anticancer research
— id: 161378, year: 1987, vol: 7, page: 161, stat: Journal Article,

ENHANCEMENT OF METHOTREXATE (MTX) EFFECTS BY DIPYRIDAMOLE (DP)
Muggia, FM; Slowiaczek, P; Subar, M; Tattersall, MHN
1987 May;5(1):135-135, Investigational new drugs
— id: 31183, year: 1987, vol: 5, page: 135, stat: Journal Article,

Clinical evaluation of anti-tumor therapy
Muggia, Franco M.; Rozencweig, Marcel
Boston : Nijhoff, 1987,
— id: 48, year: 1987, vol: , page: , stat: ,

Treatment of metastatic malignant melanoma with dacarbazine and cisplatin
Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
1987 Sep;71(9):877-878, Cancer treatment reports
— id: 15693, year: 1987, vol: 71, page: 877, stat: Journal Article,

Advanced ovarian cancer: three-year results of a 6-8 month, 2-drug cisplatin-containing regimen
Piccart MJ; Speyer JL; Wernz JC; Noumoff J; Beller U; Beckman M; Dubin N; Demopoulos R; Muggia F
1987 Jun;23(6):631-641, European journal of cancer & clinical oncology
— id: 11393, year: 1987, vol: 23, page: 631, stat: Journal Article,

Epirubicin activity in pancreatic carcinoma and hepatoma
Speyer, J; Green, M; Hochster, H; Wernz, J; Blum, R; Muggia, F
1987 ;24(SUPPL. 1):181-190, Clinical trials journal
— id: 585252, year: 1987, vol: 24, page: 181, stat: Journal Article,

Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro
Wadler, S; Green, M D; Basch, R; Muggia, F M
1987 May;36(9):1495-1501, Biochemical pharmacology
— id: 161377, year: 1987, vol: 36, page: 1495, stat: Journal Article,

Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma
Wadler, S; Subar, M; Green, M D; Wiernik, P H; Muggia, F M
1987 Sep;71(9):821-824, Cancer treatment reports
— id: 161375, year: 1987, vol: 71, page: 821, stat: Journal Article,

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer
Williams, S D; Stablein, D M; Einhorn, L H; Muggia, F M; Weiss, R B; Donohue, J P; Paulson, D F; Brunner, K W; Jacobs, E M; Spaulding, J T
1987 Dec;317(23):1433-1438, New England journal of medicine
— id: 161374, year: 1987, vol: 317, page: 1433, stat: Journal Article,

Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional disease
Blum RH; Cooper J; Schmidt AM; Ashinoff R; Collins A; Wernz JC; Speyer JL; Boyd A; Muggia FM
1986 Mar;70(3):333-337, Cancer treatment reports
— id: 15695, year: 1986, vol: 70, page: 333, stat: Journal Article,

Immune modulating therapy in gastrointestinal cancer
Chachoua A; Green M; Muggia FM
1986 Aug;81(8):623-628, American journal of gastroenterology
— id: 14636, year: 1986, vol: 81, page: 623, stat: Journal Article,

Activity of epirubicin in pancreatic carcinoma
Hochster H; Green MD; Speyer JL; Wernz JC; Blum RH; Muggia FM
1986 Feb;70(2):299-300, Cancer treatment reports
— id: 15696, year: 1986, vol: 70, page: 299, stat: Journal Article,

Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial
Hochster HS; Green MD; Blum RH; Wernz JC; Speyer JL; Muggia FM
1986 ;4(3):275-278, Investigational new drugs
— id: 15697, year: 1986, vol: 4, page: 275, stat: Journal Article,

Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer
Krasnow, S; Green, M; Perry, D J; Eisenberger, M A; Johnston-Early, A; Muggia, F; Cohen, M H
1986 Aug;70(8):1039-1040, Cancer treatment reports
— id: 161267, year: 1986, vol: 70, page: 1039, stat: Journal Article,

Kaposi's sarcoma and AIDS
Muggia, F M; Lonberg, M
1986 Jan;70(1):139-154, Medical clinics of North America
— id: 161383, year: 1986, vol: 70, page: 139, stat: Journal Article,

CONCURRENT ADMINISTRATION OF INTERFERON-ALPHA-2 (IFN) AND DOXORUBICIN (DOX)
SPEYER, JL; GREEN, MD; WERNZ, JC; DUNLEAVY, S; BLUM, RH; WIDMAN, T; MUGGIA, FM
1986 MAR ;27(2):182-182, Proceedings (American Association for Cancer Research)
— id: 41428, year: 1986, vol: 27, page: 182, stat: Journal Article,

Apparent myocardial ischemia associated with vinblastine administration
Subar, M; Muggia, F M
1986 May;70(5):690-691, Cancer treatment reports
— id: 161381, year: 1986, vol: 70, page: 690, stat: Journal Article,

Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck
Vogl SE; Komisar A; Kaplan BH; Engstrom PF; Kasule OH; Stolbach L; Lerner H; Muggia F
1986 Feb 15;57(4):706-710, Cancer
— id: 27127, year: 1986, vol: 57, page: 706, stat: Journal Article,

Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell line
Wadler, S; Green, M D; Muggia, F M
1986 Mar;46(3):1176-1181, Cancer research
— id: 161382, year: 1986, vol: 46, page: 1176, stat: Journal Article,

CELL-CYCLE ANALYSIS TO EVALUATE THE INTERACTION BETWEEN DOXORUBICIN (DOX) AND THE CARDIOPROTECTIVE AGENT, ICRF-187
WADLER, S; GREEN, MD; BASCH, R; MUGGIA, FM
1986 MAR ;27(2):370-370, Proceedings (American Association for Cancer Research)
— id: 41429, year: 1986, vol: 27, page: 370, stat: Journal Article,

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
Bennett, J M; Byrne, P; Desai, A; White, C; DeConti, R; Vogel, C; Krementz, E; Muggia, F; Doroshow, J; Plotkin, D
1985 ;3(2):179-185, Investigational new drugs
— id: 161271, year: 1985, vol: 3, page: 179, stat: Journal Article,

Liver cancer
Bottino, Joseph C.; Opfell, Richard W.; Muggia, Franco M
Boston : Nijhoff, 1985,
— id: 37, year: 1985, vol: , page: , stat: ,

Down's syndrome and testicular cancer: a possible association
Braun DL; Green MD; Rausen AR; David R; Wolman SR; Alba Greco M; Muggia FM
1985 Summer;7(2):208-211, American journal of pediatric hematology-oncology
— id: 18128, year: 1985, vol: 7, page: 208, stat: Journal Article,

Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study
Earhart, R H; Muggia, F M; Golomb, F M
1985 ;3(3):297-301, Investigational new drugs
— id: 78069, year: 1985, vol: 3, page: 297, stat: Journal Article,

Doxorubicin and interferon: rationale and clinical experience
Green, M D; Speyer, J; Wernz, J; Kisner, D; Koeller, J; Blum, R; Von Hoff, D; Muggia, F
1985 Dec;12 Suppl B:61-67, Cancer treatment reviews
— id: 161268, year: 1985, vol: 12 Suppl B, page: 61, stat: Journal Article,

A PHASE-I STUDY OF THE CONCURRENT ADMINISTRATION OF ALPHA-2- INTERFERON AND DOXORUBICIN
Green, MD; Speyer, JL; Wernz, JC; Blum, RH; Dunleavy, S; Widman, T; Muggia, FM
1985 ;33(3):A767-A767, Clinical research
— id: 30846, year: 1985, vol: 33, page: A767, stat: Journal Article,

Single-dose dacarbazine and dactinomycin in advanced malignant melanoma
Hochster H; Levin M; Speyer J; Dunleavy S; Harris M; Roses D; Golomb F; Muggia F
1985 Jan;69(1):39-42, Cancer treatment reports
— id: 25132, year: 1985, vol: 69, page: 39, stat: Journal Article,

4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma
Hochster HS; Green MD; Speyer J; Fazzini E; Blum R; Muggia FM
1985 Nov;3(11):1535-1540, Journal of clinical oncology
— id: 34972, year: 1985, vol: 3, page: 1535, stat: Journal Article,

PHASE I-II STUDY OF TRIAZINATE (TZT) FOR ADVANCED HEAD AND NECK-CANCER (HNC)
Krasnow, S; Eisenberger, M; Green, M; Muggia, F; Johnstonearly, A; Hightower, E; Ortega, L; Cohen, M
1985 ;26(MAR):172-172, Proceedings (American Association for Cancer Research)
— id: 30896, year: 1985, vol: 26, page: 172, stat: Journal Article,

Pancreatic cancer: a new target for adjuvant therapy and chemotherapy
Muggia FM; Megibow A; Douglass HO Jr
1985 ;201(4):295-300, Progress in clinical & biological research
— id: 43708, year: 1985, vol: 201, page: 295, stat: Journal Article,

Ovarian cancer: new therapeutic concepts, renewed optimism
Muggia FM; Piccart MJ; Speyer JL
1985 Nov;103(5):795-797, Annals of internal medicine
— id: 35101, year: 1985, vol: 103, page: 795, stat: Journal Article,

Colorectal cancer: speculations on the role of intraperitoneal therapy
Muggia, F M
1985 Sep;12(3 Suppl 4):112-115, Seminars in oncology
— id: 161387, year: 1985, vol: 12, page: 112, stat: Journal Article,

Primary chemotherapy: concepts and issues
Muggia, F M
1985 ;201:377-383, Progress in clinical & biological research
— id: 161389, year: 1985, vol: 201, page: 377, stat: Journal Article,

Testicular cancer and the legacy of chemotherapy
Muggia, F M
1985 ;15(1):1-5, Cancer chemotherapy & pharmacology
— id: 161388, year: 1985, vol: 15, page: 1, stat: Journal Article,

Chemotherapy for locally advanced lung cancer: rationale and issues
Muggia, F M; Blum, R H; Cooper, J S; McCauley, D
1985 ;201:119-126, Progress in clinical & biological research
— id: 161390, year: 1985, vol: 201, page: 119, stat: Journal Article,

Potential for platinum analogs in the treatment of cancer of the uterine cervix
Muggia, F M; Lira-Puerto, V; Carugati, A; Pavlovsky, S
1985 Sep;12 Suppl A:93-99, Cancer treatment reviews
— id: 161385, year: 1985, vol: 12 Suppl A, page: 93, stat: Journal Article,

COLORECTAL-CANCER - SPECULATIONS ON THE ROLE OF INTRAPERITONEAL THERAPY
MUGGIA, FM
1985 ;12(3):112-115, Seminars in oncology
— id: 41185, year: 1985, vol: 12, page: 112, stat: Journal Article,

Treatment of Kaposi's sarcoma: overview and analysis by clinical setting
Odajnyk, C; Muggia, F M
1985 Sep;3(9):1277-1285, Journal of clinical oncology
— id: 161386, year: 1985, vol: 3, page: 1277, stat: Journal Article,

A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study
Pandya, K J; Muggia, F M; Skeel, R T; Falkson, G; Kaplan, B M; Ettinger, D S
1985 Oct;8(5):353-357, American journal of clinical oncology
— id: 161384, year: 1985, vol: 8, page: 353, stat: Journal Article,

[Availability and rational use of essential drugs in the treatment of cancer]
Pavlovsky, S; Muggia, F; Sackmann Muriel, F
1985 Nov;99(5):445-463, Boletin de la Oficina Sanitaria Panamericana
— id: 161269, year: 1985, vol: 99, page: 445, stat: Journal Article,

Intraperitoneal chemotherapy: technical experience at five institutions
Piccart MJ; Speyer JL; Markman M; ten Bokkel Huinink WW; Alberts D; Jenkins J; Muggia F
1985 Sep;12(3 Suppl 4):90-96, Seminars in oncology
— id: 35102, year: 1985, vol: 12, page: 90, stat: Journal Article,

A PROSPECTIVE-STUDY OF THE CORRELATION BETWEEN CA-125 SERUM LEVELS AND SURGICALLY VERIFIED TUMOR BURDEN IN OVARIAN-CANCER (OV-CA) PATIENTS (
Piccart, M; Goldhirsch, A; Davis, B; Roesler, H; Muggia, F; Speyer, J
1985 ;26(MAR):148-148, Proceedings (American Association for Cancer Research)
— id: 30894, year: 1985, vol: 26, page: 148, stat: Journal Article,

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast
Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
1985 Apr;78(4):555-563, American journal of medicine
— id: 15698, year: 1985, vol: 78, page: 555, stat: Journal Article,

The role of anthracyclines in the treatment of gastric cancer
Wadler, S; Green, M; Muggia, F
1985 Jun;12(2):105-132, Cancer treatment reviews
— id: 161270, year: 1985, vol: 12, page: 105, stat: Journal Article,

DOXORUBICIN (DOX) AND THE CARDIOPROTECTIVE AGENT, ICRF-187, HAVE ADDITIVE CYTOTOXICITIES FOR THE MURINE SARCOMA S180 CELL- LINE
Wadler, S; Green, M; Polsky, D; Muggia, F
1985 ;26(MAR):342-342, Proceedings (American Association for Cancer Research)
— id: 30898, year: 1985, vol: 26, page: 342, stat: Journal Article,

TRIAL BASED ON BIOCHEMICAL MODULATION OF 5 FLUOROURACIL (5FU) BY DAILY SEQUENTIAL HYDROXYUREA (HU) IN COLORECTAL-CANCER
Walsh, C; Speyer, JL; Wernz, JC; Blum, RH; Muggia, FM
1985 ;26(MAR):168-168, Proceedings (American Association for Cancer Research)
— id: 30895, year: 1985, vol: 26, page: 168, stat: Journal Article,

Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma
Wernz JC; Kao AK; Muggia FM; Asbury RF
1985 Feb;69(2):223-224, Cancer treatment reports
— id: 15699, year: 1985, vol: 69, page: 223, stat: Journal Article,

Malignant mesothelioma of the tunica vaginalis testis
Antman, K; Cohen, S; Dimitrov, N V; Green, M; Muggia, F
1984 May;2(5):447-451, Journal of clinical oncology
— id: 161272, year: 1984, vol: 2, page: 447, stat: Journal Article,

Cardiotoxicity of anthracyclines
Green MD; Speyer JL; Muggia FM
1984 Feb;20(2):293-296, European journal of cancer & clinical oncology
— id: 35107, year: 1984, vol: 20, page: 293, stat: Journal Article,

Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer
Green MD; Speyer JS; Bottino JC; Blum RH; Wernz JC; Muggia FM
1984 Apr;68(4):681-682, Cancer treatment reports
— id: 15703, year: 1984, vol: 68, page: 681, stat: Journal Article,

Intra-abdominal carcinomatosis with histologically normal ovaries
Hochster H; Wernz JC; Muggia FM
1984 Jun;68(6):931-932, Cancer treatment reports
— id: 15702, year: 1984, vol: 68, page: 931, stat: Journal Article,

Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer
Kao AK; Muggia FM; Dubin N; Lerner WA; Stark R; Wernz JC; Speyer JL; Blum RH
1984 Nov;68(11):1383-1385, Cancer treatment reports
— id: 15700, year: 1984, vol: 68, page: 1383, stat: Journal Article,

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine
Laubenstein LJ; Krigel RL; Odajnyk CM; Hymes KB; Friedman-Kien A; Wernz JC; Muggia FM
1984 Oct;2(10):1115-1120, Journal of clinical oncology
— id: 15701, year: 1984, vol: 2, page: 1115, stat: Journal Article,

Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study
Levin, M; Pandya, K J; Khandekar, J D; Horton, J; Glick, J H; Bennett, J M; Muggia, F M; Falkson, G
1984 Dec;68(12):1511-1512, Cancer treatment reports
— id: 161391, year: 1984, vol: 68, page: 1511, stat: Journal Article,

Activity of mitolactol in cancer of the uterine cervix
Lira-Puerto, V; Morales-Canfield, F; Wernz, J; Muggia, F M
1984 Apr;68(4):669-670, Cancer treatment reports
— id: 161393, year: 1984, vol: 68, page: 669, stat: Journal Article,

Multidisciplinary considerations in cancer treatment: origin and scope
Muggia, F M
1984 Jun;10 Suppl 1:31-33, International journal of radiation oncology biology physics
— id: 161392, year: 1984, vol: 10 Suppl 1, page: 31, stat: Journal Article,

Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies
Muggia, F M; Blum, R H; Foreman, J D
1984 Jan;10(1):137-145, International journal of radiation oncology biology physics
— id: 161395, year: 1984, vol: 10, page: 137, stat: Journal Article,

Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group study
Muggia, F M; Tsiatis, A A; O'Connell, M J; Glick, J H; Opfell, R W; Coren, A
1984 Mar;68(3):551-553, Cancer treatment reports
— id: 161394, year: 1984, vol: 68, page: 551, stat: Journal Article,

ACIVICIN - PHASE-II STUDIES WITH A 72-HOUR INFUSION SCHEDULE
MUGGIA, FM; EARHART, RH
1984 ;2(1):115-115, Investigational new drugs
— id: 40968, year: 1984, vol: 2, page: 115, stat: Journal Article,

WORKSHOP ON CHEMOPREVENTION OF BREAST-CANCER
MUGGIA, FM; GREENSPAN, EM
1984 ;44(7):3151-3154, Cancer research
— id: 40941, year: 1984, vol: 44, page: 3151, stat: Journal Article,

THERAPEUTIC STRATEGIES UTILIZING RECOMBINANT ALPHA-2-INTERFERON IN EPIDEMIC KAPOSIS SARCOMA
MUGGIA, FM; KRIGEL, RL; WERNZ, JC; SPIEGEL, RJ
1984 ;2(1):107-107, Investigational new drugs
— id: 40967, year: 1984, vol: 2, page: 107, stat: Journal Article,

PHASE-II TRIAL OF PALA IN LYMPHOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
MUGGIA, FM; TSIATIS, AA; OCONNELL, MJ; GLICK, JH; OPFELL, RW; COREN, A
1984 ;68(3):551-553, Cancer treatment reports
— id: 40964, year: 1984, vol: 68, page: 551, stat: Journal Article,

CARBOPLATIN - ACTIVITY IN PATIENTS WITH HEAD AND NECK (H+N), RENAL-CELL (RC) AND OVARIAN CARCINOMAS
OHNUMA, T; LEYVRAZ, S; COFFEY, V; BILLER, H; MUGGIA, F; HOLLAND, JF
1984 ;25(MAR):179-179, Proceedings (American Association for Cancer Research)
— id: 40805, year: 1984, vol: 25, page: 179, stat: Journal Article,

Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinoma
Schmidt AM; Blum RH; Clayton M; Speyer JL; Bottino J; Muggia FM
1984 Dec;7(6):725-727, American journal of clinical oncology
— id: 35105, year: 1984, vol: 7, page: 725, stat: Journal Article,

HUMAN-TUMOR CLONOGENIC-ASSAY - CHEMOSENSITIVITY TESTING IN SOFT AGAR AND CLINICAL CORRELATION IN MALIGNANT-MELANOMA
CUMPS, E; BOWEN, J; HARRIS, M; ROSES, D; GOLOMB, F; VALENTINE, F; MUGGIA, F; LEVIN, M
1983 ;31(2):A405-A405, Clinical research
— id: 40682, year: 1983, vol: 31, page: A405, stat: Journal Article,

Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu)
Engstrom, P F; MacIntyre, J M; Douglass, H O Jr; Muggia, F; Mittelman, A
1983 Apr;6(2):175-180, American journal of clinical oncology
— id: 161273, year: 1983, vol: 6, page: 175, stat: Journal Article,

A PILOT-STUDY OF THE CONCURRENT USE OF CIS-PLATINUM AND RADIATION-THERAPY IN ADVANCED HEAD AND NECK-CANCER
GREEN, MD; COOPER, JS; MUGGIA, FM; COHEN, N
1983 ;6(2):148-148, American journal of clinical oncology
— id: 40700, year: 1983, vol: 6, page: 148, stat: Journal Article,

Kaposi's sarcoma: a new staging classification
Krigel, R L; Laubenstein, L J; Muggia, F M
1983 Jun;67(6):531-534, Cancer treatment reports
— id: 161400, year: 1983, vol: 67, page: 531, stat: Journal Article,

A SEQUENTIAL FLUOROURACIL-HYDROXYUREA (5 FU/HU) REGIMEN FOR BOWEL AND PANCREATIC CANCERS
LERNER, WA; MUGGIA, FM; WERNZ, JC; SPEYER, JL; BLUM, RH; SPIEGEL, RJ
1983 ;31(2):A410-A410, Clinical research
— id: 40683, year: 1983, vol: 31, page: A410, stat: Journal Article,

Description of an emerging epidemic: the acquired immunodeficiency syndrome (AIDS)
Muggia, F M
1983 Dec;10(12):2429-2441, Gan to kagaku ryoho = Cancer & chemotherapy
— id: 161397, year: 1983, vol: 10, page: 2429, stat: Journal Article,

Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain
Muggia, F M
1983 Jul;9(7):1099-1100, International journal of radiation oncology biology physics
— id: 161399, year: 1983, vol: 9, page: 1099, stat: Journal Article,

N-Acetylcysteine (NAC): a significant chemoprotective adjunct. Introduction
Muggia, F M
1983 Mar;10(1 Suppl 1):1-1, Seminars in oncology
— id: 161401, year: 1983, vol: 10, page: 1, stat: Journal Article,

Patterns of hematologic toxicities from anticancer drugs
Muggia, F M
1983 Nov;1(11):741-741, Journal of clinical oncology
— id: 161398, year: 1983, vol: 1, page: 741, stat: Journal Article,

Pulmonary toxicity of antitumor agents
Muggia, F M; Louie, A C; Sikic, B I
1983 Dec;10(4):221-243, Cancer treatment reviews
— id: 161396, year: 1983, vol: 10, page: 221, stat: Journal Article,

N-ACETYLCYSTEINE (NAC) - A SIGNIFICANT CHEMOPROTECTIVE ADJUNCT - PROCEEDINGS OF A SYMPOSIUM - SEPTEMBER 8 AND 10, 1982 - INTRODUCTION
MUGGIA, FM
1983 ;10:1-1, Seminars in oncology
— id: 40698, year: 1983, vol: 10, page: 1, stat: Journal Article,

PRE-CLINICAL STUDIES - DISCUSSION
MUGGIA; UNVERFERTH; LEVY; JOHNSTON; GURTOO; HARRISON
1983 ;10(1):46-48, Seminars in oncology
— id: 50983, year: 1983, vol: 10, page: 46, stat: Journal Article,

CLINICAL-STUDIES - DISCUSSION
MUGGIA; UNVERFERTH; MYERS; MORGAN; LEVY; SLAVIK; HOLOYE; MILLER; KIM
1983 ;10(1):89-92, Seminars in oncology
— id: 50984, year: 1983, vol: 10, page: 89, stat: Journal Article,

Repeated femoral vein cannulation for administration of chemotherapeutic agents
Nidus BD; Speyer JL; Bottino J; Green M; Levin M; Muggia FM
1983 Feb;67(2):185-186, Cancer treatment reports
— id: 28278, year: 1983, vol: 67, page: 185, stat: Journal Article,

Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275)
Engstrom, P F; MacIntyre, J M; Douglass, H O Jr; Muggia, F; Mittelman, A
1982 Apr;49(8):1555-1560, Cancer
— id: 161274, year: 1982, vol: 49, page: 1555, stat: Journal Article,

The role of VM26 (teniposide, NSC 122819) in chemotherapy of cancer
Opfell, R; Muggia, F
1982 ;1(3-Feb):98-101, Chemioterapia
— id: 579102, year: 1982, vol: 1, page: 98, stat: Journal Article,

Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule
Spiegel RJ; Blum RH; Levin M; Pinto CA; Wernz JC; Speyer JL; Hoffman KS; Muggia FM
1982 Jan;42(1):354-358, Cancer research
— id: 15704, year: 1982, vol: 42, page: 354, stat: Journal Article,

PHASE-II TRIAL OF DAILY X5 BISANTRENE IN RENAL-CELL CARCINOMA
Spiegel, RJ; Levin, M; Blum, R; Speyer, J; Wernz, J; Pinto, C; Muggia, F
1982 ;23(MAR):111-111, Proceedings of the annual meeting of the American Association for Cancer Research
— id: 30412, year: 1982, vol: 23, page: 111, stat: Journal Article,

A TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (FU) IN PATIENTS (
CAMACHO, FJ; MUGGIA, FM; KAPLAN, BH
1981 ;22(MAR):457-457, Proceedings (American Association for Cancer Research)
— id: 40185, year: 1981, vol: 22, page: 457, stat: Journal Article,

Clinical trials with the hexitol derivatives in the U.S
Chiuten, D F; Rozencweig, M; Von Hoff, D D; Muggia, F M
1981 Feb;47(3):442-451, Cancer
— id: 161405, year: 1981, vol: 47, page: 442, stat: Journal Article,

Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trial
Chiuten, D F; Vosika, G J; Shaw, M T; Boiron, M; Gisselbrecht, C; Marty, M; Higgins, G; Muggia, F M
1981 ;1(2):121-124, Anticancer research
— id: 161407, year: 1981, vol: 1, page: 121, stat: Journal Article,

Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute
Goldin, A; Venditti, J M; Macdonald, J S; Muggia, F M; Henney, J E; Devita, V T Jr
1981 Feb;17(2):129-142, European journal of cancer
— id: 161406, year: 1981, vol: 17, page: 129, stat: Journal Article,

Lung cancer. Chemotherapy as curative treatment
Howard, L M; Blum, R H; Muggia, F M
1981 May;81(6):919-921, New York state journal of medicine
— id: 161404, year: 1981, vol: 81, page: 919, stat: Journal Article,

Future clinical investigations with anthracycline antibiotics in relation to daunorubicin
Muggia FM; Blum RH; Wernz JC
1981 ;65 Suppl 4:35-37, Cancer treatment reports
— id: 15705, year: 1981, vol: 65 Suppl 4, page: 35, stat: Journal Article,

Anticancer drug development and federal regulation: protection against progress?
Muggia, F M
1981 Sep;71(3):341-344, American journal of medicine
— id: 161403, year: 1981, vol: 71, page: 341, stat: Journal Article,

The Cancer Therapy Evaluation Program of the National Cancer Institute
Muggia, F M; Carter, S K; Macdonald, J S
1981 Dec;8(4):394-402, Seminars in oncology
— id: 161402, year: 1981, vol: 8, page: 394, stat: Journal Article,

Selected anticancer drugs in Phase I trials in the United States (1979--1980)
Muggia, F M; Penta, J S; Catane, R; Jensen-Akula, M S; Charles, L M Jr
1981 ;76:192-208, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161411, year: 1981, vol: 76, page: 192, stat: Journal Article,

Cisplatin: impact of a new anticancer agent on current therapeutic strategies
Rozencweig, M; Abele, R; von Hoff, D D; Muggia, F M
1981 ;1(4):199-204, Anticancer research
— id: 161408, year: 1981, vol: 1, page: 199, stat: Journal Article,

Animal toxicology for early clinical trials with anticancer agents
Rozencweig, M; Von Hoff, D D; Staquet, M J; Schein, P S; Penta, J S; Goldin, A; Muggia, F M; Freireich, E J; DeVita, V T Jr
1981 ;4(1):21-28, Cancer clinical trials
— id: 161409, year: 1981, vol: 4, page: 21, stat: Journal Article,

ADRIAMYCIN (ADM) 24 HOUR INFUSION - A PHASE-I TRIAL
SPEYER, JL; BOTTINO, J; NIDUS, B; BLUM, R; WERNZ, JC; LEVIN, M; HYMES, K; MUGGIA, FM
1981 ;22(MAR):363-363, Proceedings (American Association for Cancer Research)
— id: 40183, year: 1981, vol: 22, page: 363, stat: Journal Article,

PHASE-I TRIAL OF 9,10-ANTHRACENEDICARBOXALDEHYDE (CL216,942)
SPIEGEL, R; BLUM, R; PINTO, C; WERNZ, J; LEVIN, M; HOFFMAN, K; BLANK, J; MUGGIA, F
1981 ;22(MAR):357-357, Proceedings (American Association for Cancer Research)
— id: 40182, year: 1981, vol: 22, page: 357, stat: Journal Article,

Methodology for the assessment of new dichotomous diagnostic tests
Staquet, M; Rozencweig, M; Lee, Y J; Muggia, F M
1981 ;34(12):599-610, Journal of chronic diseases
— id: 161410, year: 1981, vol: 34, page: 599, stat: Journal Article,

Staging of testicular cancer: a proposed clinical-surgical schema
DeWys, W; Muggia, F M; Jacobs, E M
1980 Apr-May;64(4-5):669-674, Cancer treatment reports
— id: 161415, year: 1980, vol: 64, page: 669, stat: Journal Article,

Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial
Hayat, M; Brule, G; Cappelaere, P; Cattan, A; Chauvergne, J; Clavel, B; Guerrin, J; Misset, J L; Pommatau, E; Ribaud, P; Muggia, F M; Rozencweig, M; Mathe, G
1980 ;74:139-145, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161428, year: 1980, vol: 74, page: 139, stat: Journal Article,

Testicular cancer: risk factors and the role of adjuvant chemotherapy
Jacobs, E M; Muggia, F M
1980 Apr;45(7 Suppl):1782-1790, Cancer
— id: 161413, year: 1980, vol: 45, page: 1782, stat: Journal Article,

The rediscovery of DON (6-diazo-5-oxo-L-norleucine)
Kisner, D L; Catane, R; Muggia, F M
1980 ;74:258-263, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161427, year: 1980, vol: 74, page: 258, stat: Journal Article,

LOCALLY INOPERABLE PANCREATIC-CANCER - FURTHER OBSERVATIONS ON A COMBINED RADIOTHERAPY-CHEMOTHERAPY APPROACH
Levin, B; Wernz, J; Kinzie, J; Moossa, A; Newall, J; Blum, R; Muggia, F
1980 ;21(MAR):419-419, Proceedings (American Association for Cancer Research)
— id: 27995, year: 1980, vol: 21, page: 419, stat: Journal Article,

Long-term survivors with small cell carcinoma of the lung
Matthews, M J; Rozencweig, M; Staquet, M J; Minna, J D; Muggia, F M
1980 Apr;16(4):527-531, European journal of cancer
— id: 161416, year: 1980, vol: 16, page: 527, stat: Journal Article,

Treatment of primary breast cancer. Summary of the National Institutes of Health Consensus Development Conference
Moxley, J H 3rd; Allegra, J C; Henney, J; Muggia, F
1980 Aug;244(8):797-800, JAMA
— id: 161275, year: 1980, vol: 244, page: 797, stat: Journal Article,

Chemo- and immunopharmacology: the reality and the horizons of cancer treatment
Muggia, F M
1980 ;75:260-260, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161426, year: 1980, vol: 75, page: 260, stat: Journal Article,

General progress in clinical chemotherapy of advanced disease
Muggia, F M; Henney, J; DeVita, V Jr
1980 ;74:1-7, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161431, year: 1980, vol: 74, page: 1, stat: Journal Article,

Phase II trials: use of a clinical tumor panel and overview of current resources and studies
Muggia, F M; Rozencweig, M; Chiuten, D F; Jensen-Akula, M S; Charles, L M Jr; Kubota, T T; Bono, V H Jr
1980 Jan;64(1):1-9, Cancer treatment reports
— id: 161419, year: 1980, vol: 64, page: 1, stat: Journal Article,

Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease
Muggia, F M; Rozencweig, M; Louie, A E
1980 Jan-Feb;2(3):196-205, Head & neck surgery
— id: 161421, year: 1980, vol: 2, page: 196, stat: Journal Article,

Clinical implications of cisplatin pharmacology
Muggia, F M; Rozencweig, M; Penta, J
1980 ;74:132-138, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161429, year: 1980, vol: 74, page: 132, stat: Journal Article,

Methodology phase II clinical trial in cancer
Muggia, F M; Rozencweig, M; Staquet, M J; McGuire, W P Jr
1980 ;70:53-60, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161425, year: 1980, vol: 70, page: 53, stat: Journal Article,

Intraarterial chemotherapy of head and neck cancer: worth another look?
Muggia, F M; Wolf, G T
1980 ;3(4):375-379, Cancer clinical trials
— id: 161418, year: 1980, vol: 3, page: 375, stat: Journal Article,

Comments on the carcinogenic, mutagenic, and teratogenic properties of anticancer drugs
Muggia, F M; Ziegler, J
1980 ;74:306-311, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161423, year: 1980, vol: 74, page: 306, stat: Journal Article,

Methodology of phase II and III clinical trials in cancer. It use by cooperative groups
Muggia, F; Alvarez, CA; Estevez, RA; Woolley, PV
1980 ;12(1):9-16, Revista Latinoamericana de oncologia clinica
— id: 580352, year: 1980, vol: 12, page: 9, stat: Journal Article,

ROLE OF CHEMOTHERAPY IN HEAD AND NECK-CANCER - SYSTEMIC USE OF SINGLE AGENTS AND COMBINATIONS IN ADVANCED DISEASE
Muggia, FM; Rozencweig, M; Louie, AE
1980 ;2(3):196-205, Head & neck surgery
— id: 27934, year: 1980, vol: 2, page: 196, stat: Journal Article,

Preclinical and phase I studies of malonatoplatinum
Ribaud, P; Kelsen, D P; Alcock, N; Garcia-Giralt, E; Dubouch, P; Young, C C; Muggia, F M; Burchenal, J H; Mathe, G
1980 ;74:156-162, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161424, year: 1980, vol: 74, page: 156, stat: Journal Article,

N-(Phosphonacetyl)-L-aspartate (PALA): current status
Rozencweig, M; Abele, R; Piccart, M; Von Hoff, D D; Muggia, F M
1980 ;74:72-77, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161422, year: 1980, vol: 74, page: 72, stat: Journal Article,

Surgical adjuvant trials in the United States
Rozencweig, M; Von Hoff, D D; Allegra, J C; Muggia, F M
1980 ;Suppl 1:173-177, European journal of cancer
— id: 161420, year: 1980, vol: Suppl 1, page: 173, stat: Journal Article,

m-AMSA: a new anticancer agent
Rozencweig, M; Von Hoff, D D; Legha, S S; Cysyk, R L; Muggia, F M
1980 ;74:250-257, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161432, year: 1980, vol: 74, page: 250, stat: Journal Article,

Actual and potential combinations of radiation and chemotherapy with clinical benefits
Rubin, P; Muggia, F M; D'Angio, G J
1980 Jul;6(7):963-966, International journal of radiation oncology biology physics
— id: 161412, year: 1980, vol: 6, page: 963, stat: Journal Article,

Therapeutic progress in ovarian cancer, testicular cancer, and the sarcomas
van Oosterom, AT; Muggia, Franco M; Cleton, FJ
Hingham, MA : Kluwer, 1980,
— id: 2245, year: 1980, vol: , page: , stat: ,

Treatment of small cell undifferentiated carcinoma of the lung: update of recent results
Weiss, R B; Minna, J D; Glatstein, E; Martini, N; Ihde, D C; Muggia, F M
1980 Apr-May;64(4-5):539-548, Cancer treatment reports
— id: 161414, year: 1980, vol: 64, page: 539, stat: Journal Article,

Cytotoxic drug-induced pulmonary disease: update 1980
Weiss, R B; Muggia, F M
1980 Feb;68(2):259-266, American journal of medicine
— id: 161417, year: 1980, vol: 68, page: 259, stat: Journal Article,

Long-term sequelae of cancer chemotherapy
Ziegler, J; Muggia, F M
1980 ;74:312-315, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161430, year: 1980, vol: 74, page: 312, stat: Journal Article,

Pulmonary toxicity after radiation and bleomycin: a review
Catane, R; Schwade, J G; Turrisi, A T 3rd; Webber, B L; Muggia, F M
1979 Sep;5(9):1513-1518, International journal of radiation oncology biology physics
— id: 161440, year: 1979, vol: 5, page: 1513, stat: Journal Article,

Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity
Catane, R; Von Hoff, D D; Glaubiger, D L; Muggia, F M
1979 Jun;63(6):1033-1038, Cancer treatment reports
— id: 161446, year: 1979, vol: 63, page: 1033, stat: Journal Article,

VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)
Chiuten, D F; Bennett, J M; Creech, R H; Glick, J; Falkson, G; Brodovsky, H S; Begg, C B; Muggia, F M; Carbone, P P
1979 Jan;63(1):7-11, Cancer treatment reports
— id: 161454, year: 1979, vol: 63, page: 7, stat: Journal Article,

Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26
Chiuten, D F; Muggia, F M; Johnson, R K
1979 Nov-Dec;63(11-12):1857-1862, Cancer treatment reports
— id: 161436, year: 1979, vol: 63, page: 1857, stat: Journal Article,

International activities of the Division of Cancer Treatment, National Cancer Institute
Goldin, A; Muggia, F M; Rozencweig, M
1979 Spring;2(1):29-35, Cancer clinical trials
— id: 161450, year: 1979, vol: 2, page: 29, stat: Journal Article,

Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents
Guarino, A M; Rozencweig, M; Kline, I; Penta, J S; Venditti, J M; Lloyd, H H; Holzworth, D A; Muggia, F M
1979 Jun;39(6 Pt 1):2204-2210, Cancer research
— id: 161444, year: 1979, vol: 39, page: 2204, stat: Journal Article,

[Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial]
Hayat, M; Bayssas, M; Brule, G; Cappelaere, P; Cattan, A; Chauvergne, J; Clavel, B; Gouveia, J; Guerrin, J; Pommatau, E; Muggia, F; Mathe, G
1979 Mar;8(15):1231-1234, La nouvelle presse medicale
— id: 161278, year: 1979, vol: 8, page: 1231, stat: Journal Article,

Chemotherapy of testicular cancer: from palliation to curative adjuvant therapy
Jacobs, E M; Muggia, F M; Rozencweig, M
1979 Mar;6(1):3-13, Seminars in oncology
— id: 161451, year: 1979, vol: 6, page: 3, stat: Journal Article,

Current adjuvant trials in colorectal cancer
Kisner, D L; Davis, H L Jr; Muggia, F M
1979 ;5:102-115, Frontiers of gastrointestinal research
— id: 161455, year: 1979, vol: 5, page: 102, stat: Journal Article,

Analysis and interpretation of response rates for anticancer drugs
Lee, Y J; Catane, R; Rozencweig, M; Bono, V H Jr; Muggia, F M; Simon, R; Staquet, M J
1979 Nov-Dec;63(11-12):1713-1720, Cancer treatment reports
— id: 161435, year: 1979, vol: 63, page: 1713, stat: Journal Article,

Two-stage plans for patient accrual in phase II cancer clinical trials
Lee, Y J; Staquet, M; Simon, R; Catane, R; Muggia, F
1979 Nov-Dec;63(11-12):1721-1726, Cancer treatment reports
— id: 161276, year: 1979, vol: 63, page: 1721, stat: Journal Article,

Immunological profile of breast cancer patients in early or advanced disease
Menconi, E; Barzi, A; Greco, M; Caprino, M C; De Vecchis, L; Muggia, F
1979 Jun;35(6):820-822, Experientia
— id: 161277, year: 1979, vol: 35, page: 820, stat: Journal Article,

Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types
Mikulski, S M; McGuire, W P; Louie, A C; Chirigos, M A; Muggia, F M
1979 Sep;6(3):177-190, Cancer treatment reviews
— id: 161439, year: 1979, vol: 6, page: 177, stat: Journal Article,

Immunotherapy of lung cancer. II. Review of clinical trials in small cell carcinoma
Mikulski, S M; McGuire, W P; Louie, A C; Chirigos, M A; Muggia, F M
1979 Jun;6(2):125-130, Cancer treatment reviews
— id: 161448, year: 1979, vol: 6, page: 125, stat: Journal Article,

Amino acid manipulations in cancer treatment: a perspective from the National Cancer Institute Workshop
Muggia, F M; Catane, R; Douros, J; Cooney, D
1979 Jun;63(6):1137-1138, Cancer treatment reports
— id: 161445, year: 1979, vol: 63, page: 1137, stat: Journal Article,

Summary of investigations on platinum compounds and radiation interactions
Muggia, F M; Glatstein, E
1979 Aug;5(8):1407-1409, International journal of radiation oncology biology physics
— id: 161442, year: 1979, vol: 5, page: 1407, stat: Journal Article,

Lung cancer : progress in therapeutic research
Muggia, Franco M.; Rozencweig, Marcel
New York : Raven Press, 1979,
— id: 172, year: 1979, vol: , page: , stat: ,

Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice
Ovejera, A A; Houchens, D P; Catane, R; Sheridan, M A; Muggia, F M
1979 Aug;39(8):3220-3224, Cancer research
— id: 161441, year: 1979, vol: 39, page: 3220, stat: Journal Article,

Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials
Penta, J S; Rozencweig, M; Guarino, A M; Muggia, F M
1979 ;3(2):97-101, Cancer chemotherapy & pharmacology
— id: 161453, year: 1979, vol: 3, page: 97, stat: Journal Article,

Anthracycline derivatives in new drug development programs
Rozencweig, M; De Sloover, C; Von Hoff, D D; Tagnon, H J; Muggia, F M
1979 May;63(5):807-808, Cancer treatment reports
— id: 161449, year: 1979, vol: 63, page: 807, stat: Journal Article,

m-AMSA and PALA: two new agents in cancer chemotherapy
Rozencweig, M; Von Hoff, D D; Cysyk, R L; Muggia, F M
1979 ;3(3):135-141, Cancer chemotherapy & pharmacology
— id: 161452, year: 1979, vol: 3, page: 135, stat: Journal Article,

The delta and epsilon errors in the assessment of cancer clinical trials
Staquet, M J; Rozencweig, M; Von Hoff, D D; Muggia, F M
1979 Nov-Dec;63(11-12):1917-1921, Cancer treatment reports
— id: 161434, year: 1979, vol: 63, page: 1917, stat: Journal Article,

Risk factors for doxorubicin-induced congestive heart failure
Von Hoff, D D; Layard, M W; Basa, P; Davis, H L Jr; Von Hoff, A L; Rozencweig, M; Muggia, F M
1979 Nov;91(5):710-717, Annals of internal medicine
— id: 161433, year: 1979, vol: 91, page: 710, stat: Journal Article,

The evaluation of cytotoxic drugs
Von Hoff, D D; Rozencweig, M; Muggia, F M
1979 Jun;6 Suppl:1-8, Cancer treatment reviews
— id: 161447, year: 1979, vol: 6 Suppl, page: 1, stat: Journal Article,

Toxic effects of cis-dichlorodiammineplatinum(II) in man
Von Hoff, D D; Schilsky, R; Reichert, C M; Reddick, R L; Rozencweig, M; Young, R C; Muggia, F M
1979 Sep-Oct;63(9-10):1527-1531, Cancer treatment reports
— id: 161438, year: 1979, vol: 63, page: 1527, stat: Journal Article,

Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU)
Weiss, R B; Muggia, F M
1979 Jul;91(1):131-132, Annals of internal medicine
— id: 161443, year: 1979, vol: 91, page: 131, stat: Journal Article,

Working conference on mesothelioma treatment trials
Weiss, R B; Muggia, F M
1979 Sep;39(9):3799-3800, Cancer research
— id: 161437, year: 1979, vol: 39, page: 3799, stat: Journal Article,

High-dose methotrexate, not a conventional treatment
Catane, R; Bono, V H Jr; Louie, A C; Muggia, F M
1978 Jan;62(1):178-180, Cancer treatment reports
— id: 161472, year: 1978, vol: 62, page: 178, stat: Journal Article,

The chemotherapy of Hodgkin's disease: past experiences and future directions
DeVita, V T Jr; Lewis, B J; Rozencweig, M; Muggia, F M
1978 Aug;42(2 Suppl):979-990, Cancer
— id: 161459, year: 1978, vol: 42, page: 979, stat: Journal Article,

Correlation between in vitro labeling indices (LIs) and tumor regression following radiotherapy
Elequin, F T; Muggia, F M; Ghossein, N A; Ager, P J; Krishnaswamy, V
1978 Mar-Apr;4(3-4):207-213, International journal of radiation oncology biology physics
— id: 161463, year: 1978, vol: 4, page: 207, stat: Journal Article,

Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26
Gad-el-Mawla, N M; Muggia, F M; Hamza, M R; El-Morsi, B; Sherif, M; Mansour, M A; Khafagy, M; El-Sebai, I T
1978 Jul;62(7):993-996, Cancer treatment reports
— id: 161462, year: 1978, vol: 62, page: 993, stat: Journal Article,

Hormonal therapy of breast cancer: new approaches and concepts
Legha, S S; Davis, H L; Muggia, F M
1978 Jan;88(1):69-77, Annals of internal medicine
— id: 161468, year: 1978, vol: 88, page: 69, stat: Journal Article,

Problems in the development of cytotoxic moieties linked to hormones
Lippman, M E; Heuson, J C; Muggia, F M
1978 Aug;62(8):1267-1268, Cancer treatment reports
— id: 161460, year: 1978, vol: 62, page: 1267, stat: Journal Article,

Effective adjuvant treatments. A brief review of U.S. clinical trials
Louie, A C; Rozencweig, M; von Hoff, D D; Muggia, F M
1978 ;48(7):653-658, Archiv fur Geschwulstforschung
— id: 161471, year: 1978, vol: 48, page: 653, stat: Journal Article,

Visual abnormalities following nitrosourea treatment
Louie, A C; Turrisi, A T; Muggia, F M; Bono, V H Jr
1978 ;5(1):245-247, Medical & pediatric oncology
— id: 161474, year: 1978, vol: 5, page: 245, stat: Journal Article,

Immune modulation and cancer control
Mikulski, S M; Chirigos, M A; Muggia, F M
1978 ;15:263-287, Advances in pharmacology & chemotherapy
— id: 161467, year: 1978, vol: 15, page: 263, stat: Journal Article,

Clinical evaluation of new antitumor antibiotics
Muggia, F M
1978 ;63:288-297, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161478, year: 1978, vol: 63, page: 288, stat: Journal Article,

Clinical trials in cancer: general concepts and methodologies
Muggia, F M
1978 Summer;1(2):139-144, Cancer clinical trials
— id: 161461, year: 1978, vol: 1, page: 139, stat: Journal Article,

New anticancer drugs
Muggia, F M; Bono, V H Jr; DeVita, V T Jr
1978 ;23:42-49, Antibiotics & chemotherapy (1971)
— id: 161469, year: 1978, vol: 23, page: 42, stat: Journal Article,

Radiotherapy and chemotherapy in combined clinical trials: problems and promise
Muggia, F M; Cortes-Funes, H; Wasserman, T H
1978 Jan-Feb;4(1-2):161-171, International journal of radiation oncology biology physics
— id: 161473, year: 1978, vol: 4, page: 161, stat: Journal Article,

Moral dilemmas in clinical cancer experimentation
Muggia, F M; DeVita, V T
1978 ;4(2):181-181, Medical & pediatric oncology
— id: 161475, year: 1978, vol: 4, page: 181, stat: Journal Article,

Proceedings of the Osteosarcoma Study Group Meeting (Bethesda, Maryland, January 19, 1977): introduction: treatment of osteogenic sarcoma
Muggia, F M; Handelsman, H
1978 Feb;62(2):187-188, Cancer treatment reports
— id: 161466, year: 1978, vol: 62, page: 187, stat: Journal Article,

Treatment of early breast cancer, and reconstruction
Muggia, F M; Henney, J E
1978 Dec;2(8101):1210-1210, Lancet
— id: 161457, year: 1978, vol: 2, page: 1210, stat: Journal Article,

Adjuvant chemotherapy of testicular carcinoma: need for evaluation of curative strategies
Muggia, F M; Jacobs, E M
1978 ;68:192-200, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161477, year: 1978, vol: 68, page: 192, stat: Journal Article,

Five years of adjuvant treatment of osteosarcoma: more questions than answers
Muggia, F M; Louie, A C
1978 Feb;62(2):301-305, Cancer treatment reports
— id: 161465, year: 1978, vol: 62, page: 301, stat: Journal Article,

Adjuvant systemic therapy of lung cancer
Muggia, F M; McGuire, W P 3rd
1978 Fall;1(3):235-241, Cancer clinical trials
— id: 161458, year: 1978, vol: 1, page: 235, stat: Journal Article,

Adjuvant systemic therapy of cancer: rationale for future trials
Muggia, F M; Rozencweig, M
1978 ;68:431-438, Recent results in cancer research = Fortschritte der Krebsforschung = Progres dans les recherches sur le cancer
— id: 161476, year: 1978, vol: 68, page: 431, stat: Journal Article,

Current trends and prospects in surgical adjuvant trials
Rozencweig, M; von Hoff, D D; Louie, A C; Muggia, F M
1978 ;48(7):673-679, Archiv fur Geschwulstforschung
— id: 161470, year: 1978, vol: 48, page: 673, stat: Journal Article,

Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?
Rozencweig, M; Zelen, M; Von Hoff, D D; Muggia, F M
1978 Dec;299(24):1363-1364, New England journal of medicine
— id: 161456, year: 1978, vol: 299, page: 1363, stat: Journal Article,

"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue
Von Hoff, D D; Rozencweig, M; Louie, A C; Bender, R A; Muggia, F M
1978 Feb;62(2):233-235, Cancer treatment reports
— id: 161464, year: 1978, vol: 62, page: 233, stat: Journal Article,

ICRF-159: current status and clinical prospects
Bellet, R E; Rozencweig, M; Von Hoff, D D; Penta, J S; Wasserman, T H; Muggia, F M
1977 Nov;13(11):1293-1298, European journal of cancer
— id: 161483, year: 1977, vol: 13, page: 1293, stat: Journal Article,

Chemotherapy of alveolar soft part sarcoma: a case report
Berenzweig, M S; Muggia, F M; Kaplan, B H
1977 Jan-Feb;61(1):77-79, Cancer treatment reports
— id: 161499, year: 1977, vol: 61, page: 77, stat: Journal Article,

A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspirates
Elequin, F T; Muggia, F M; Ghossein, N A; Schreiber, K
1977 Jul-Aug;21(4):596-599, Acta cytologica
— id: 161488, year: 1977, vol: 21, page: 596, stat: Journal Article,

Pleural mesothelioma: clinical features and therapeutic implications
Legha, S S; Muggia, F M
1977 Nov;87(5):613-621, Annals of internal medicine
— id: 161481, year: 1977, vol: 87, page: 613, stat: Journal Article,

Therapeutic approaches in malignant mesothelioma
Legha, S S; Muggia, F M
1977 Mar;4(1):13-23, Cancer treatment reviews
— id: 161495, year: 1977, vol: 4, page: 13, stat: Journal Article,

Adjuvant chemotherapy in lung cancer: review and prospects
Legha, S S; Muggia, F M; Carter, S K
1977 Apr;39(4):1415-1424, Cancer
— id: 161493, year: 1977, vol: 39, page: 1415, stat: Journal Article,

Adjuvant chemotherapy: correct advice
Louie, A; Von Hoff, D D; Rozencweig, M; Muggia, F
1977 Apr;237(16):1691-1691, JAMA
— id: 161279, year: 1977, vol: 237, page: 1691, stat: Journal Article,

Chronic aggressive hepatitis--a disorder of desuppression?
Mikulski, S M; Muggia, F M
1977 Feb;296(6):341-341, New England journal of medicine
— id: 161497, year: 1977, vol: 296, page: 341, stat: Journal Article,

The biologic activity of MER-BCG in experimental systems and preliminary clinical studies
Mikulski, S M; Muggia, F M
1977 Jun;4(2):103-117, Cancer treatment reviews
— id: 161492, year: 1977, vol: 4, page: 103, stat: Journal Article,

Tuftsin - unimportant or forgotten
Mikulski, S W; Von Hoff, D D; Rozencweig, M; Muggia, F M
1977 Feb;296(8):454-454, New England journal of medicine
— id: 161496, year: 1977, vol: 296, page: 454, stat: Journal Article,

Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinoma
Muggia, F M; Chia, G; Reed, L J; Romney, S L
1977 Jun;128(3):314-319, American journal of obstetrics & gynecology
— id: 161490, year: 1977, vol: 128, page: 314, stat: Journal Article,

Current cooperative clinical trials in the non-Hodgkin's lymphomas
Muggia, F M; Davis, H L Jr; Rozencweig, M
1977 Sep;61(6):1191-1197, Cancer treatment reports
— id: 161485, year: 1977, vol: 61, page: 1191, stat: Journal Article,

Observations on the human pharmacology of cycloleucine
Muggia, F M; Loew, J; Horwitz, S
1977 Nov;61(8):1561-1563, Cancer treatment reports
— id: 161482, year: 1977, vol: 61, page: 1561, stat: Journal Article,

Hepatotoxicity of combination chemotherapy for acute myelocytic leukemia
Penta, J S; Von Hoff, D D; Muggia, F M
1977 Aug;87(2):247-248, Annals of internal medicine
— id: 161486, year: 1977, vol: 87, page: 247, stat: Journal Article,

VM 26 and VP 16-213: a comparative analysis
Rozencweig, M; Von Hoff, D D; Henney, J E; Muggia, F M
1977 Jul;40(1):334-342, Cancer
— id: 161489, year: 1977, vol: 40, page: 334, stat: Journal Article,

Investigational chemotherapeutic agents in head and neck cancer
Rozencweig, M; Von Hoff, D D; Muggia, F M
1977 Dec;4(4):425-429, Seminars in oncology
— id: 161480, year: 1977, vol: 4, page: 425, stat: Journal Article,

Cis-diamminedichloroplatinum (II). A new anticancer drug
Rozencweig, M; von Hoff, D D; Slavik, M; Muggia, F M
1977 Jun;86(6):803-812, Annals of internal medicine
— id: 161491, year: 1977, vol: 86, page: 803, stat: Journal Article,

Time relationship between last dose of daunorubicin and congestive heart failure
Von Hoff, D D; Layard, M; Rozencweig, M; Muggia, F M
1977 Oct;61(7):1411-1413, Cancer treatment reports
— id: 161484, year: 1977, vol: 61, page: 1411, stat: Journal Article,

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases
Von Hoff, D D; Rozencweig, M; Layard, M; Slavik, M; Muggia, F M
1977 Feb;62(2):200-208, American journal of medicine
— id: 161498, year: 1977, vol: 62, page: 200, stat: Journal Article,

Cytembena: an anticancer drug with an unique structure
Von Hoff, D D; Rozencweig, M; Muggia, F M
1977 Dec;26(6):388-392, Biomedicine
— id: 161479, year: 1977, vol: 26, page: 388, stat: Journal Article,

Estramustine phosphate: a specific chemotherapeutic agent?
Von Hoff, D D; Rozencweig, M; Slavik, M; Muggia, F M
1977 Apr;117(4):464-466, Journal of urology
— id: 161494, year: 1977, vol: 117, page: 464, stat: Journal Article,

Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents
Von Hoff, D D; Rozencweig, M; Soper, W T; Helman, L J; Penta, J S; Davis, H L; Muggia, F M
1977 Aug;61(5):759-768, Cancer treatment reports
— id: 161487, year: 1977, vol: 61, page: 759, stat: Journal Article,

Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung
Edmonson, J H; Lagakos, S W; Selawry, O S; Perlia, C P; Bennett, J M; Muggia, F M; Wampler, G; Brodovsky, H S; Horton, J; Colsky, J; Mansour, E G; Creech, R; Stolbach, L; Greenspan, E M; Levitt, M; Israel, L; Ezdinli, E Z; Carbone, P P
1976 Jul;60(7):925-932, Cancer treatment reports
— id: 161503, year: 1976, vol: 60, page: 925, stat: Journal Article,

De novo Kaposi's sarcoma in renal transplantation. Case report and brief review
Hardy, M A; Goldfarb, P; Levine, S; Dattner, A; Muggia, F M; Levitt, S; Weinstein, E
1976 Jul;38(1):144-148, Cancer
— id: 161502, year: 1976, vol: 38, page: 144, stat: Journal Article,

The "other" asparaginase
Hrushesky, W J; Slavik, M; Penta, J; Muggia, F
1976 ;2(4):441-442, Medical & pediatric oncology
— id: 161280, year: 1976, vol: 2, page: 441, stat: Journal Article,

Letter: Antiestrogens in the treatment of cancer
Legha, S; Muggia, F M
1976 Jun;84(6):751-751, Annals of internal medicine
— id: 161504, year: 1976, vol: 84, page: 751, stat: Journal Article,

Overview of early and investigational chemotherapeutic agents in solid tumors
Rozencweig, M; Slavik, M; Muggia, F M; Carter, S K
1976 ;2(4):417-432, Medical & pediatric oncology
— id: 161506, year: 1976, vol: 2, page: 417, stat: Journal Article,

Activity of daunomycin in solid tumors
Von Hoff, D D; Rozencweig, M; Slavik, M; Muggia, F M
1976 Oct;236(15):1693-1693, JAMA
— id: 161500, year: 1976, vol: 236, page: 1693, stat: Journal Article,

5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia
Von Hoff, D D; Slavik, M; Muggia, F M
1976 Aug;85(2):237-245, Annals of internal medicine
— id: 161501, year: 1976, vol: 85, page: 237, stat: Journal Article,

Letter: Allergic reactions to cis platinum
Von Hoff, D D; Slavik, M; Muggia, F M
1976 Jan;1(7950):90-90, Lancet
— id: 161505, year: 1976, vol: 1, page: 90, stat: Journal Article,

Irradiated lung cancer. An autopsy analysis of spread pattern
Abadir, R; Muggia, F M
1975 Feb;114(2):427-430, Radiology
— id: 161512, year: 1975, vol: 114, page: 427, stat: Journal Article,

Phase I clinical trial of isophosphamide (NSC-109724)
Cohen, M H; Creaven, P J; Tejada, F; Hansen, H H; Muggia, F; Mittelman, A; Selawry, O S
1975 Jul-Aug;59(4):751-755, Cancer chemotherapy reports. Pt 1
— id: 161281, year: 1975, vol: 59, page: 751, stat: Journal Article,

Radiation-related eosinophilia. Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapy
Ghossein, N A; Bosworth, J L; Stacey, P; Muggia, F M; Krishnaswamy, V
1975 Nov;117(2):413-417, Radiology
— id: 161507, year: 1975, vol: 117, page: 413, stat: Journal Article,

Letter: Treatment of small-cell carcinoma of bronchus
Muggia, F M; Hansen, H H; Dombernowsky, P
1975 Mar;1(7908):692-692, Lancet
— id: 161511, year: 1975, vol: 1, page: 692, stat: Journal Article,

Ectopic placental proteins in nontrophoblastic tumors. Serial measurements following chemotherapy
Muggia, F M; Rosen, S W; Weintraub, B D; Hansen, H H
1975 Oct;36(4):1327-1337, Cancer
— id: 161508, year: 1975, vol: 36, page: 1327, stat: Journal Article,

Carcinoma of thyroid gland. Associated with systemic amyloidosis and nephrotic syndrome
Perloff, M; Muggia, F M
1975 Sep;75(10):1770-1771, New York state journal of medicine
— id: 161509, year: 1975, vol: 75, page: 1770, stat: Journal Article,

Letter: Treatment of "pancreatic cholera"
Siegel, S R; Muggia, F M
1975 Jul;293(4):198-198, New England journal of medicine
— id: 161510, year: 1975, vol: 293, page: 198, stat: Journal Article,

Diagnosis of liver metastases in bronchogenic carcinoma. A comparative study of liver scans, function tests, and peritoneoscopy with liver biopsy in 111 patients
Margolis, R; Hansen, H H; Muggia, F M; Kanhouwa, S
1974 Nov;34(5):1825-1829, Cancer
— id: 161514, year: 1974, vol: 34, page: 1825, stat: Journal Article,

Cell kinetic studies in patients with lung cancer
Muggia, F M
1974 ;30(5):353-361, Oncology (New York)
— id: 161519, year: 1974, vol: 30, page: 353, stat: Journal Article,

Lung cancer: diagnosis in metastatic sites
Muggia, F M; Chervu, L R
1974 Sep;1(3):217-228, Seminars in oncology
— id: 161517, year: 1974, vol: 1, page: 217, stat: Journal Article,

Cell kinetic studies in patients with small cell carcinoma of the lung
Muggia, F M; Krezoski, S K; Hansen, H H
1974 Nov;34(5):1683-1690, Cancer
— id: 161513, year: 1974, vol: 34, page: 1683, stat: Journal Article,

Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation
Muggia, F M; Perloff, M; Chia, G A; Reed, L J; Escher, G C
1974 Nov-Dec;58(6):919-926, Cancer chemotherapy reports. Pt 1
— id: 161515, year: 1974, vol: 58, page: 919, stat: Journal Article,

Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer
Perloff, M; Muggia, F M; Ackerman, C
1974 May-Jun;58(3):421-424, Cancer chemotherapy reports. Pt 1
— id: 161518, year: 1974, vol: 58, page: 421, stat: Journal Article,

Breast cancer in men. Report illustrating the value of endocrine ablation
Stephens, R L; Muggia, F M
1974 Oct;57(4):679-682, American journal of medicine
— id: 161516, year: 1974, vol: 57, page: 679, stat: Journal Article,

Letter: Ectopic production of calcitonin
Hansen, H H; Muggia, F M
1973 Oct;2(7834):915-915, Lancet
— id: 161520, year: 1973, vol: 2, page: 915, stat: Journal Article,

Correlation of histologic types with cell kinetic studies in lung cancer
Muggia, F M
1973 Mar;4(2):69-71, Cancer chemotherapy reports. Pt 3
— id: 161524, year: 1973, vol: 4, page: 69, stat: Journal Article,

Hyperkalaemia and chemotherapy
Muggia, F M
1973 Mar;1(7803):602-603, Lancet
— id: 161523, year: 1973, vol: 1, page: 602, stat: Journal Article,

Eosinophilia following radiation therapy
Muggia, F M; Ghossein, N A; Wohl, H
1973 ;27(2):118-127, Oncology (New York)
— id: 161525, year: 1973, vol: 27, page: 118, stat: Journal Article,

The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changes
Napoli, L D; Hansen, H H; Muggia, F M; Twigg, H L
1973 Jul;108(1):17-21, Radiology
— id: 161521, year: 1973, vol: 108, page: 17, stat: Journal Article,

Hypercalcemia in epidermoid tumors of the head and neck and esophagus
Stephens, R L; Hansen, H H; Muggia, F M
1973 Jun;31(6):1487-1491, Cancer
— id: 161522, year: 1973, vol: 31, page: 1487, stat: Journal Article,

Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity
Creaven, P J; Allen, L M; Muggia, F M
1972 Oct;56(5):573-578, Cancer chemotherapy reports. Pt 1
— id: 161528, year: 1972, vol: 56, page: 573, stat: Journal Article,

Staging of inoperable patients with bronchogenic carcinoma with special reference to bone marrow examination and peritoneoscopy
Hansen, H H; Muggia, F M
1972 Nov;30(5):1395-1401, Cancer
— id: 161526, year: 1972, vol: 30, page: 1395, stat: Journal Article,

Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma
Hansen, H H; Muggia, F M; Andrews, R; Selawry, O S
1972 Aug;30(2):315-324, Cancer
— id: 161531, year: 1972, vol: 30, page: 315, stat: Journal Article,

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies
Muggia, F M; Creaven, P J; Hansen, H H; Cohen, M H; Selawry, O S
1972 Aug;56(4):515-521, Cancer chemotherapy reports. Pt 1
— id: 161532, year: 1972, vol: 56, page: 515, stat: Journal Article,

In vivo tumor cell kinetic studies: use of local thymidine injection followed by fine-needle aspiration
Muggia, F M; DeVita, V T
1972 Aug;80(2):297-301, Journal of laboratory & clinical medicine
— id: 161533, year: 1972, vol: 80, page: 297, stat: Journal Article,

Osteoblastic metastases in small-cell (oat-cell) carcinoma of the lung
Muggia, F M; Hansen, H H
1972 Sep;30(3):801-805, Cancer
— id: 161529, year: 1972, vol: 30, page: 801, stat: Journal Article,

Exploratory laparotomy in reticulum cell sarcoma. A retrospective analysis
Muggia, F M; Ultmann, J E
1972 Aug;30(2):454-458, Cancer
— id: 161530, year: 1972, vol: 30, page: 454, stat: Journal Article,

Clinical study with bleomycin: tolerance to twice weekly dosage
Onuma, T; Selawry, O S; Holland, J F; DeVita, V T Jr; Shedd, D P; Hansen, H H; Muggia, F M
1972 Oct;30(4):914-922, Cancer
— id: 161527, year: 1972, vol: 30, page: 914, stat: Journal Article,

Early detection of bone-marrow invasion in oat-cell carcinoma of the lung
Hansen, H H; Muggia, F M
1971 Apr;284(17):962-963, New England journal of medicine
— id: 161538, year: 1971, vol: 284, page: 962, stat: Journal Article,

Treatment of malignant brain tumors with nitrosoureas
Hansen, H H; Muggia, F M
1971 Apr;55(2):99-100, Cancer chemotherapy reports. Pt 1
— id: 161540, year: 1971, vol: 55, page: 99, stat: Journal Article,

Cyclophosphamide and the urinary bladder
Hansen, H H; Muggia, F M; Saini, N
1971 May;284(18):1043-1044, New England journal of medicine
— id: 161537, year: 1971, vol: 284, page: 1043, stat: Journal Article,

Bone-marrow examination in 100 consecutive patients with bronchogenic carcinoma
Hansen, H H; Muggia, F M; Selawry, O S
1971 Aug;2(7722):443-445, Lancet
— id: 161536, year: 1971, vol: 2, page: 443, stat: Journal Article,

Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037)
Hansen, H H; Selawry, O S; Muggia, F M; Walker, M D
1971 Mar;31(3):223-227, Cancer research
— id: 161541, year: 1971, vol: 31, page: 223, stat: Journal Article,

Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819)
Muggia, F M; Selawry, O S; Hansen, H H
1971 Dec;55(5):575-581, Cancer chemotherapy reports. Pt 1
— id: 161534, year: 1971, vol: 55, page: 575, stat: Journal Article,

Glomerulonephritis or nephrotic syndrome in malignant lymphoma, reticulum-cell type
Muggia, F M; Ultmann, J E
1971 Apr;1(7703):805-805, Lancet
— id: 161539, year: 1971, vol: 1, page: 805, stat: Journal Article,

Reticulum cell sarcoma of the spinal epidural space
Muggia, F M; Ultmann, J E
1971 Sep;75(3):477-478, Annals of internal medicine
— id: 161535, year: 1971, vol: 75, page: 477, stat: Journal Article,

Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate
Chua, D T; Veenema, R J; Muggia, F; Graff, A
1970 Apr;103(4):462-466, Journal of urology
— id: 161282, year: 1970, vol: 103, page: 462, stat: Journal Article,

Hypercalcemia in cancer
Horton, J; Olsen, K B; Muggia, F M; Heinemann, H O
1970 Dec;73(6):1047-1048, Annals of internal medicine
— id: 135840, year: 1970, vol: 73, page: 1047, stat: Journal Article,

Vascular factors in acute pancreatitis
Muggia, F M
1970 Jan;1(7640):245-245, Lancet
— id: 161543, year: 1970, vol: 1, page: 245, stat: Journal Article,

Creatine phosphokinase and other serum enzymes during radiotherapy. Comparison of cardiac vs noncardiac irradiation
Muggia, F M; Ghossein, N A; Hanok, A
1970 Feb;211(8):1345-1350, JAMA
— id: 161542, year: 1970, vol: 211, page: 1345, stat: Journal Article,

Hypercalcemia associated with neoplastic disease
Muggia, F M; Heinemann, H O
1970 Aug;73(2):281-290, Annals of internal medicine
— id: 135841, year: 1970, vol: 73, page: 281, stat: Journal Article,

Treatment of advanced Hodgkin's disease with vinblastine (NSC-49842) or procarbazine (NSC-77213)
Flatow, F A; Ultmann, J E; Hyman, G A; Muggia, F M
1969 Feb;53(1):39-47, Cancer chemotherapy reports. Pt 1
— id: 161547, year: 1969, vol: 53, page: 39, stat: Journal Article,

Carcinoma of female urethra. Occurrence with hyperparathyroidism
Huvos, A G; Muggia, F M; Markewitz, M
1969 Jul;69(14):2042-2045, New York state journal of medicine
— id: 161546, year: 1969, vol: 69, page: 2042, stat: Journal Article,

Critical complications in patients with cancer: prevention and treatment
Muggia, F M
1969 Oct;97(10):124-133, Medical times
— id: 161544, year: 1969, vol: 97, page: 124, stat: Journal Article,

Hormonal management of breast cancer
Muggia, F M
1969 Jul;3(5663):179-179, British medical journal (1857-1980)
— id: 161545, year: 1969, vol: 3, page: 179, stat: Journal Article,

Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia
Muggia, F M; Heinemann, H O; Farhangi, M; Osserman, E F
1969 Sep;47(3):351-366, American journal of medicine
— id: 135843, year: 1969, vol: 47, page: 351, stat: Journal Article,

Gynecologic manifestations of reticulum cell sarcoma
Iliya, F A; Muggia, F M; O'Leary, J A; King, T M
1968 Feb;31(2):266-269, Obstetrics & gynecology
— id: 161549, year: 1968, vol: 31, page: 266, stat: Journal Article,

Treatment of breast cancer with medroxyprogesterone acetate
Muggia, F M; Cassieth, P A; Ochoa, M Jr; Flatow, F A; Gellhorn, A; Hyman, G A
1968 Feb;68(2):328-337, Annals of internal medicine
— id: 161548, year: 1968, vol: 68, page: 328, stat: Journal Article,

Constrictive pericarditis following radiation therapy
Muggia, F M; Cassileth, P A
1968 Jan;44(1):116-123, American journal of medicine
— id: 161550, year: 1968, vol: 44, page: 116, stat: Journal Article,

Hemorrhagic necrosis of the intestine: its occurrence with digitalis intoxication
Muggia, F M
1967 Mar;253(3):263-271, American journal of the medical sciences
— id: 161552, year: 1967, vol: 253, page: 263, stat: Journal Article,

Allopurinol in the treatment of neoplastic disease complicated by hyperuricemia
Muggia, F M; Ball, T J Jr; Ultmann, J E
1967 Jul;120(1):12-18, Archives of internal medicine
— id: 161551, year: 1967, vol: 120, page: 12, stat: Journal Article,

Megaloblastic anemia associated with parenchymal hemosiderosis
Muggia, F M; Olivetti, R G
1967 Feb;67(3):444-451, New York state journal of medicine
— id: 161553, year: 1967, vol: 67, page: 444, stat: Journal Article,

Neuropathic fracture. Unusual complication in a patient with advanced diabetic neuropathy
Muggia, F M
1965 Jan;191(4):336-338, JAMA
— id: 161555, year: 1965, vol: 191, page: 336, stat: Journal Article,

OSTEOGENIC SARCOMA OF THE ILIUM; REPORT OF A CASE ASSOCIATED WITH OSTEOBLASTIC PROSTATIC ADENOCARCINOMA
MUGGIA, F M; TENNANT, R
1965 Apr;47:500-510, Journal of bone & joint surgery (American volume)
— id: 161554, year: 1965, vol: 47, page: 500, stat: Journal Article,

OSLER'S DISEASE WITH AN AORTIC ARCH ANEURYSM; REPORT OF A CASE
MUGGIA, F M
1964 Aug;114:307-310, Archives of internal medicine
— id: 161556, year: 1964, vol: 114, page: 307, stat: Journal Article,